Binder compositions and uses thereof

Information

  • Patent Grant
  • 11939460
  • Patent Number
    11,939,460
  • Date Filed
    Wednesday, March 27, 2019
    5 years ago
  • Date Issued
    Tuesday, March 26, 2024
    a month ago
Abstract
A binder used for manufacturing a composite product is prepared by combining i) Maillard reactants selected from: reducing sugar reactant(s) and nitrogen-containing reactant(s); curable reaction product(s) of reducing sugar reactant(s) and nitrogen-containing reactant(s); and combinations thereof; and ii) a resin; reactants of a resin; and combinations thereof.
Description
FIELD OF THE INVENTION

The present invention relates to binder compositions and uses thereof.


More specifically the present invention relates to curable binder composition for use in manufacturing composite products from non or loosely assembled matter and to methods of manufacturing a composite product.


SUMMARY

In accordance with one aspect, the present invention provides a method of manufacturing a composite product comprising:

    • applying a binder composition, notably in the form of an aqueous solution, to non or loosely assembled matter to provide resinated matter, wherein the binder composition consists of a binder composition prepared by combining i) Maillard reactants selected from: reducing sugar reactant(s) and nitrogen-containing reactant(s); curable reaction product(s) of reducing sugar reactant(s) and nitrogen-containing reactant(s); and combinations thereof; and ii) a resin; reactants of a resin; and combinations thereof;
    • arranging the resinated matter to provide loosely arranged resinated matter; and
    • subjecting the loosely arranged resinated matter to heat and/or pressure to cure the binder composition and to form the composite product.


In accordance with another aspect, the present invention provides a binder composition consisting of a binder composition prepared by combining i) Maillard reactants selected from: reducing sugar reactant(s) and nitrogen-containing reactant(s); curable reaction product(s) of reducing sugar reactant(s) and nitrogen-containing reactant(s); and combinations thereof; and ii) a resin; reactants of a resin; and combinations thereof.





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1 shows 4-(aminomethyl)-1,8-octanediamine;



FIG. 2 shows an example of TPTA triprimary triamine (“AMOD”);



FIG. 3 shows results of a thermal stability study for binder compositions; and



FIG. 4 shows results of a temporal viscosity study.





DETAILED DESCRIPTION

Preparation of the binder composition may comprise combining reactants comprising at least 15% by dry weight reducing sugar reactant(s) and at least 2% by dry weight nitrogen-containing reactant(s), notably wherein the nitrogen-containing reactant(s) comprise TPTA triprimary triamine(s), notably wherein the nitrogen-containing reactant(s) comprise at least 5% by dry weight of TPTA triprimary triamine(s).


As used herein, the term “TPTA triprimary triamine(s)” means triprimary triamine(s) selected from:

    • triprimary triamine(s) having spacer groups between each of the three primary amines which consist of carbon chains;
    • triprimary triamine(s) having spacer groups between each of the three primary amines wherein each spacer group has a spacer length which is less than or equal to 12 polyvalent atoms; and
    • triprimary triamine(s) having a total number of polyvalent atoms which is less than or equal to 23.


Any feature described herein in relation to a particular aspect of the invention may be used in relation to any other aspect of the invention.


The non or loosely assembled matter may comprise woven or non-woven fiber material. The non or loosely assembled matter may be selected from fibers, notably selected from inorganic fibers, man-made organic fibers, mineral fibers, stone fibers, glass fibers, aramid fibers, ceramic fibers, metal fibers, carbon fibers, polyimide fibers, polyester fibers, rayon fibers, cellulosic fibers and combinations thereof. The non or loosely assembled matter may be selected from particulates, notably selected from inorganic particles, sand, coal. The non or loosely assembled matter may be selected from flakes, wood shavings, saw dust, wood pulp, paper pulp, ground wood, wood chips, wood strands, wood layers; other natural fibers, such as jute, flax, hemp, straw, and wood veneers, and combinations thereof.


In a preferred embodiment, the composite product is selected from corrugated cardboard, a corrugated board, a corrugated fiberboard, a corrugated box and a cellulosic fiber composition (notably a paper product or a cardboard product). Notably in such cases, the binder composition may be used to bond corrugated flutes to a liner board or liner paper. The composite product may be mineral fiber insulation product, for example glass fiber mat or stone fiber mat. The composite products may be a mineral fiber veil, e.g. glass fiber veil, which may then find application for example in battery separators, as substrate for roofing products, as roofing membranes, as shingles, or as other membranes. The composite product may be prepregs, high pressure laminates, refractory bricks, foundry sands, brake pads or corrugated cardboard. The composite product may be wood board, notably a particle board; an oriented strand board (OSB), plywood or a medium density fiberboard (MDF).


The term “binder composition” as used herein means all ingredients that will be applied to the non or loosely assembled matter and/or present on the non or loosely assembled matter, notably prior to curing, (other than the non or loosely assembled matter itself and any moisture in the non or loosely assembled matter), including reactants, solvents (including water) and additives. The term “dry weight of the binder composition” as used herein means the weight of all components of the binder composition other than any water that is present (whether in the form of liquid water or in the form of water of crystallization). The reactants may make up ≥80%, ≥90% or ≥95% and/or ≤99% or ≤98% by dry weight of the binder composition.


The binder composition applied to the non or loosely assembled matter comprises reactants which cross-link when cured to form a cured binder which holds the non or loosely assembled matter together to form the composite product. The binder composition comprises reactants that will preferably form a thermoset resin upon curing. The resin is preferably a reactant. The combination in the binder composition of the Maillard reactants with the resin (and/or resin reactants) may be used to impart improved weather resistance, water repellence and/or waterproofing properties compared with the resin (and/or resin reactants) when used alone, notably for articles comprising waterproof and/or water-resistant starch based binders.


The binder composition is preferably free of, or comprises no more than 2 wt % or no more than 5 wt % by dry weight of formaldehyde resin, notably formaldehyde resin selected from melamine formaldehyde resin, melamine urea formaldehyde resin, urea formaldehyde resin, phenol formaldehyde resin, melamine phenol formaldehyde resin, ketone formaldehyde resin and combinations thereof. The binder composition may be prepared by combining reactants comprising, consisting essentially of or consisting of the reducing sugar reactant(s) and the nitrogen-containing reactant(s) and the resin (and/or resin reactants). In the form in which it is applied to the non or loosely assembled matter the binder composition may comprise (a) the reducing sugar reactant(s) and the nitrogen-containing reactant(s) and/or (b) curable reaction product(s) of the reducing sugar reactant(s) and the nitrogen-containing reactant(s).


The binder composition may comprise a resin and/or reactants thereof where the resin is selected from latex resin, formaldehyde resin, notably formaldehyde resin selected from melamine formaldehyde resin, melamine urea formaldehyde resin, urea formaldehyde resin, phenol formaldehyde resin, melamine phenol formaldehyde resin, ketone formaldehyde resin, carboxymethyl-cellulose-based resin, starch-based resin, polyurethane resin, polyurea and polyurethane hybrid, rubber resin Bakelite, Diallyl-phthalate resin, epoxy resin, epoxy novolac resin, benzoxazine resins used alone or hybridised with epoxy and/or phenolic resins, polyimide resins, bismaleimide resins cyanate ester resins, polycyanurate resins, furan resins, silicone resins, thiolyte resins, vinyl ester resins, styrene acrylic resins, acrylic resins, vinyl acrylic resins, styrene butadiene resins, vinyl acetate homopolymer resins, ethylene vinyl acetate resins, acrylic vinylidene chloride, resins and blends and/or and combinations thereof. The binder composition may comprise a resin and/or reactants thereof selected from latex resin, carboxymethyl-cellulose-based resin, starch-based resin and combinations thereof. The binder composition may comprise at least 50 wt % or at least 60 wt %, or even at least 70 wt % by dry weight of the resin and/or reactants thereof.


The term “loosely arranged resinated matter” as used herein means that the resinated matter is assembled together with sufficient integrity for the resinated matter to be processed along a production line but without the resinated matter being permanently joined together in a way that is achieved by fully cross-linking the binder composition. Prior to curing, the binder composition preferably provides a stickiness or tackiness which holds that loosely arranged matter together.


As used herein, the term “consist or consisting essentially of” is intended to limit the scope of a statement or claim to the specified materials or steps and those that do not materially affect the basic and novel characteristic(s) of the invention.


The reducing sugar reactant(s) may comprise: a monosaccharide, a monosaccharide in its aldose or ketose form, a disaccharide, a polysaccharide, a triose, a tetrose, a pentose, xylose, a hexose, dextrose, fructose, a heptose, or mixtures thereof. The reducing sugar reactant(s) may be yielded in situ by carbohydrate reactant(s), notably carbohydrate reactant(s) having a dextrose equivalent of at least about 50, at least about 60, at least about 70, at least about 80 or at least about 90, notably carbohydrate reactant(s) selected from the group consisting of molasses, starch, starch hydrolysate, cellulose hydrolysates, and mixtures thereof. The reducing sugar reactant(s) may comprise or consist of a combination of dextrose and fructose, for example in which the combination of dextrose and fructose makes up at least 80 wt % of the reducing sugar reactant(s) and/or in which the dextrose makes up at least 40 wt % of the reducing sugar reactant(s) and/or in which the fructose makes up at least 40 wt % of the reducing sugar reactant(s); the reducing sugar reactant(s) may comprise or consist of high fructose corn syrup (HFCS). The reducing sugar reactant(s) may comprise or consist of reducing sugar reactant(s) yielded in situ by sucrose. The reducing sugar reactant(s) may comprise reducing sugar reactant(s) selected from the group consisting of xylose, arabinose dextrose, mannose, fructose and combinations thereof, for example making up at least 80 wt % of the reducing sugar reactant(s).


As used herein, the term “nitrogen-containing reactant(s)” means one or more chemical compound which contain(s) at least one nitrogen atom and which is/are capable of reacting with the reducing sugar reactant(s); preferably the nitrogen-containing reactant(s) consist of Maillard reactant(s), that is to say reactant(s) which is/are capable of reacting with the reducing sugar reactant(s) as part of a Maillard reaction.


The nitrogen-containing reactant(s) comprise, and may consist essentially of or consist of, triprimary triamine(s) having spacer groups between each of the three primary amines which consist of carbon chains. The triprimary triamine(s) may be selected from the group consisting of triaminodecanes, triaminononanes, notably 4-(aminomethyl)-1,8-octanediamine, triaminooctanes, triaminoheptanes, notably 1,4,7-triaminoheptane, triaminohexanes, notably 1,3,6-triaminohexane, triaminopentanes, and including isomers and combination thereof.


As used herein the term “triprimary triamine(s)” means organic compound having three and only three amines, each of the three amines being primary amines (—NH2). One, two or each of the primary amine(s) of the triprimary triamine(s) may be present in the form of a salt, e.g as an ammonium group (—NH3+).


As used herein, the term “spacer group” in the terminology “the spacer group(s) separating each of the three primary amines” means a chain separating two primary amines. As used herein, the term “the spacer group(s) separating each primary amines in the molecule consists of carbon chains” means that the spacer group(s) consist only of carbon atoms bonded to hydrogen atoms or bonded to other carbon atoms. The triprimary triamine(s) having spacer groups between each of the three primary amines which consist of carbon chains thus consist of the three primary amines and carbon and hydrogen atoms. For example, when the spacer group(s) separating each primary amine in the molecule consists of carbon chains, no heteroatoms are present in the spacer groups.


The spacer group(s) may be selected from the group consisting of alkanediyls, heteroalkanediyls, alkenediyls, heteroalkenediyls, alkynediyls, heteroalkynediyls, linear alkanediyls, linear heteroalkanediyls, linear alkenediyls, linear heteroalkenediyls, linear alkynediyls, linear heteroalkynediyls, cycloalkanediyls, cycloheteroalkanediyls, cycloalkenediyls, cycloheteroalkenediyls, cycloalkynediyls and cycloheteroalkynediyls, each of which may be branched or unbranched. The spacer group(s) may be selected from the group consisting of alkanediyls, alkenediyls, alkynediyls, linear alkanediyls, linear alkenediyls, linear alkynediyls, cycloalkanediyls, cycloalkenediyls and cycloalkynediyls, each of which may be branched or unbranched. The spacer group may comprise or may be devoid of halogen atoms. The spacer groups may comprise or be devoid of aromatic groups. As used herein: the term “alkanediyl” means a saturated chain of carbon atoms ie without carbon-carbon double or triple bonds; the term “alkenediyl” means a chain of carbon atoms that comprises at least one carbon-carbon double bond; the term “alkynediyl” means a chain of carbon atoms that comprises at least one carbon-carbon triple bond; the term “cyclo” in relation to cycloalkanediyl, cycloalkenediyl and cycloalkynediyl indicates that at least a portion of the chain is cyclic and also includes polycyclic structures; and the term “linear” in relation to alkanediyls, alkenediyls and alkynediyls indicates an absence of a cyclic portion in the chain. As used herein, the term “hetero” in relation to heteroalkanediyls, heteroalkenediyls, heteroalkynediyls, linear heteroalkanediyls, linear heteroalkenediyls, linear heteroalkynediyls, cycloheteroalkanediyls, cycloheteroalkenediyls, and cycloheteroalkynediyls means that the chain comprises at least one polyvalent heteroatom. As used herein, the term heteroatom is any atom that is not carbon or hydrogen. As used herein, the term polyvalent atom means an atom that is able to be covalently bonded to at least 2 other atoms. The polyvalent heteroatom may be oxygen; it may be silicon; it may be sulfur or phosphorus. One, two or preferably each of the spacer groups may have a total number of polyvalent atoms, or a total number of carbon atoms which is ≥3, ≥4 or ≥5 and/or ≤12, ≤10 or ≤9. One, two or preferably each of the spacer groups may have a spacer length which is ≥3, ≥4 or ≥5 and/or ≤12, ≤10 or ≤9. As used herein, the term “spacer length” in relation to a spacer group separating two primary amines means the number of polyvalent atoms which form the shortest chain of covalently bonded atoms between the two primary amines. Each of the spacer groups between the three primary amines of the TPTA triprimary triamine(s) may: consist of an alkanediyl; and/or be linear; and/or be unbranched; and/or have a number of carbon atoms which is ≥3 or ≥4 and/or ≤9 or ≤3; and or have a spacer length which is ≥3 or ≥4 and/or ≤9 or ≤8. The total number of the polyvalent atoms of the TPTA triprimary triamine(s) may be ≥9, ≥11 or ≥12 and/or ≤23, ≤21, ≤19 or ≤17.


The nitrogen-containing reactant(s) may comprise reactant(s) selected from the group consisting of: inorganic amines, organic amines, organic amines comprising at least one primary amine, salts of an organic amine comprising at least one primary amine, polyamines, polyprimary polyamines and combinations thereof, any of which may be substituted or unsubstituted. The nitrogen-containing reactant(s) may comprise NH3, NH3 may be used as such (e.g. in form of an aqueous solution), or as an inorganic or organic ammonium salt, for example ammonium sulfate (AmSO4), ammonium phosphate, e.g. diammonium phosphate or ammonium citrate, e.g. triammonium citrate, or as a source of NH3, e.g. urea. As used herein, the term “polyamine” means any organic compound having two or more amine groups and the term “polyprimary polyamine” means an organic compound having two or more primary amines (—NH2). As used herein the term “substituted” means the replacement of one or more hydrogen atoms with other functional groups. Such other functional groups may include hydroxyl, halo, thiol, alkyl, haloalkyl, heteroalkyl, aryl, arylalkyl, arylheteroalkyl, nitro, sulfonic acids and derivatives thereof, carboxylic acids and derivatives thereof.


The polyprimary polyamine may be a diamine, triamine, tetramine, or pentamine. As used herein the term “diamine” means organic compound having two (and only two) amines, “triamine” means organic compound having three (and only three) amines, “tetramine” means organic compound having four (and only four) amines and “pentamine” means organic compound having five (and only five) amines. For example, the polyprimary amine may be: a triamine selected from diethylenetriamine (which is a diprimary triamine, i.e. diethylenetriamine has three amines, two of them being primary amines) or bis(hexamethylene)triamine; a tetramine, notably triethylenetetramine; or a pentamine, notably tetraethylenepentamine. The polyprimary polyamine may comprise or consiste essentially of diprimary diamine, notably 1,6-diaminohexane (hexamethylenediamine, HMDA) or 1,5-diamino-2-methylpentane (2-methyl-pentamethylenediamine). The nitrogen-containing reactant(s) may comprise or consist essentially of TPTA triprimary triamine(s).


The binder composition may comprise, consist essentially of or consist of a binder composition obtained or obtainable by combining reactants wherein:


the reducing sugar reactant(s) make up:






    • ≥10%, ≥15%, ≥20% by dry weight of the reactant(s), and/or

    • <50%, ≤45%, ≤40%, ≤35% by dry weight of the reactant(s), and/or


      the nitrogen-containing reactant(s) make up:

    • ≥2%, ≥3%, ≥4%, ≥5% by dry weight of the reactant(s), and/or

    • ≤15%, ≤14%, ≤12%, ≤10% by dry weight of the reactant(s), and

    • the resin and/or reactant(s) thereof make up:

    • ≥50%, ≥60%, ≥65%, ≥70%, ≥75%, ≥80%, ≥85%, ≥90%; by dry weight of the reactant(s); and/or

    • ≤99%, ≤98% or ≤95%, ≤90% by dry weight of the reactant(s).


      A diprimary diamine and/or TPTA triprimary triamine(s) may make up:

    • ≥2%, ≥3%, ≥4%, ≥5%, and/or

    • ≤15%, ≤14%, ≤12%, ≤10%


      by dry weight of the reactants of the binder composition.


      A diprimary diamine and/or TPTA triprimary triamine(s) may make up:

    • ≥5%, ≥10%, ≥15%, ≥20%, ≥30%, ≥40%, ≥50%, ≥60%, ≥65%; and/or

    • ≤95%, ≤90%, ≤85%, ≤80%, ≤70%, ≤60%, ≤50%, ≤45%, ≤30%


      by dry weight of the nitrogen-containing reactants.


      The TPTA triprimary triamine(s) may make up: ≥90% and ≤99%; or ≥80% and ≤90%; or ≥60% and ≤80%; by dry weight of the nitrogen-containing reactants; Particularly in the aforementioned cases, the remaining nitrogen-containing reactants may comprise amines and/or nitriles.





The ratio of carbonyl groups in the reducing sugar reactant(s) to reactive amino groups in the nitrogen-containing reactant(s) may be in the range of 5:1 to 1:2. For example, the ratio of carbonyl groups to reactive amino groups may be in the range of 5:1 to 1:1.8, 5:1 to 1:1.5, 5:1 to 1:1.2, 5:1 to 1:1, 5:1 to 1:0.8 and 5:1 to 1:0.5. Further examples include ratios such as 4:1 to 1:2, 3.5:1 to 1:2, 3:1 to 1:2, 2.5:1 to 1:2, 2:1 to 1:2 and 1.5:1 to 1:2. As used herein, the term “reactive amino group” means any amino group in the nitrogen-containing reactant(s) which is capable of reacting with the reducing sugar reactant(s). Specifically, examples of such reactive amino groups comprise primary and secondary amine(s).


The nitrogen-containing reactant(s) and the reducing sugar reactant(s) are preferably Maillard reactants. The nitrogen-containing reactant(s) and the reducing sugar reactant(s) (or their reaction product(s)) preferably react to form Maillard reaction products, notably melanoidins when cured. The cured binder composition may comprise melanoidin-containing and/or nitrogenous-containing polymer(s). The cured binder composition is preferably a thermoset binder and is preferably substantially water insoluble.


The binder composition and/or the cured binder may comprise ester and/or polyester compounds.


All the reducing sugar reactant(s) and all the nitrogen-containing reactant(s) of the binder composition may be combined in a single preparation step, for example by dissolving the reducing sugar reactant(s) in water and then adding the nitrogen-containing reactant(s). The term “single preparation step” is used herein to differentiate from a “multiple preparation step” preparation in which a first portion of reactants are combined and stored and/or allowed to react for a pre-determined time before addition of further reactants.


Alternatively, the reducing sugar reactant(s) and the nitrogen containing reactant(s) of the binder composition may be combined by:

    • combining reducing sugar reactant(s), notably all of the reducing sugar reactant(s), with a first portion of the nitrogen-containing reactant(s) to provide an intermediate mixture of reducing sugar reactant(s) and nitrogen containing reactant(s),
    • storing the intermediate mixture of reducing sugar reactant(s) and nitrogen containing reactant(s); and
    • combining the intermediate mixture of reducing sugar reactant(s) and nitrogen containing reactant(s) with a second portion of the nitrogen-containing reactant(s) to provide the mixture of all reducing sugar reactant(s) and all nitrogen containing reactant(s).


      The intermediate mixture of reducing sugar reactant(s) and nitrogen containing reactant(s) may comprise, consist essentially of or consist of reaction products of the reducing sugar reactant(s), with a first portion of the nitrogen-containing reactant(s). The reactants may be heated to provide the intermediate mixture of reducing sugar reactant(s) and nitrogen containing reactant(s); the intermediate mixture of reducing sugar reactant(s) and nitrogen containing reactant(s) may be subsequently cooled.


      The first and second portions of nitrogen-containing reactant(s) may be the same nitrogen-containing reactant(s) or, alternatively they may be different nitrogen-containing reactant(s). Only one of the first and second portion of nitrogen-containing reactant(s), or alternatively each of the first and second portion of nitrogen-containing reactant(s), may comprise, consist essentially of or consist of a diprimary diamine and/or TPTA triprimary triamine(s).


As used herein “storing the intermediate mixture of reducing sugar reactant(s) and nitrogen containing reactant(s)” means that the intermediate mixture of reducing sugar reactant(s) and nitrogen containing reactant(s) is stored or shipped for a prolonged time, notably without crystallization of the reducing sugar reactant(s) or gelling which would render the binder composition unusable. The intermediate mixture of reducing sugar reactant(s) and nitrogen containing reactant(s) may be stored for a period of at least 30 min, at least 1 h, at least 4 h, at least 12 h, at least 24 h, at least 96 h, at least 1 week, at least 2 weeks, or at least 4 weeks.


Preparation of the binder composition may comprise:


a) combining in a single preparation step: the reducing sugar reactant(s); the nitrogen containing reactant(s) and; a resin and/or reactants thereof;


b) combining a resin and/or reactants thereof with an intermediate mixture of reducing sugar reactant(s) and nitrogen containing reactant(s); or


c) combining a resin and/or reactants thereof with a mixture comprising the totality of the reducing sugar reactant(s) and nitrogen containing reactant(s).


The binder composition may comprise one or more additive, for example one or more additives selected from waxes, dyes dedusting oil, release agents, formaldehyde scavengers (for example urea, tannins, quebracho extract, ammonium phosphate, bisulfite), water repellent agent, silanes, silicones, lignins, lignosulphonates and non-carbohydrate polyhydroxy component selected from glycerol, polyethylene glycol, polypropylene glycol, trimethylolpropane, pentaerythritol, polyvinyl alcohol, partially hydrolyzed polyvinyl acetate, fully hydrolyzed polyvinyl acetate, or mixtures thereof. Such additives are generally not reactants of the binder composition, that is to say they so do not cross-link with the reducing sugar and/or the nitrogen containing reactant(s) (or reaction products thereof) as part of the curing of the binder composition.


The binder composition may be applied to the non or loosely assembled matter in the form of a liquid, notably in the form of an aqueous composition, for example comprising an aqueous solution or dispersion, notably in which the dry weight of the aqueous binder composition makes up: ≥5 wt %, ≥10 wt %, ≥15 wt %, ≥20 wt % or ≥25 wt % and/or ≤95 wt %, ≤90 wt %, ≤85 wt % or ≤80 wt % of the total weight of the aqueous binder composition. Alternatively, the binder composition may be applied to the non or loosely assembled matter in the form of a solid, for example as a powder or as particles. The binder composition may be applied by being sprayed. The binder composition may be applied to the non or loosely assembled matter by passing the non or loosely assembled matter through a spray of the binder composition or by spraying the binder composition over the non or loosely assembled matter. The binder composition may be applied by being spread, for example as a continuous layer or as a discontinuous layer, for example as lines of binder. Other application techniques include roll application, dip coating and dry mixing.


The present disclosure further provides for curable, formaldehyde free binder compositions that impart commercially beneficial properties to finished articles such as corrugated boards, wood and composite boards, and insulation articles. In certain embodiments, these properties include but are not limited to weather resistance, water repellence and waterproofing. In additional embodiments, articles and commercial products comprising the binder compositions disclosed herein are advantageously recyclable and/or repulpable.


Without being bound by theory, it has been found that when introducing a compound capable of forming a carbamate compound, e.g. by bubbling carbon dioxide through a solution comprising a) the reducing sugar reactant(s) and nitrogen-containing reactant(s) and/or b) curable reaction product(s) of reducing sugar reactant(s) and nitrogen-containing reactant(s), the presence of one or more carbamate compounds is capable of delaying or preventing further reaction of the nitrogen-containing reactant(s) and/or curable reaction product(s) of reducing sugar reactant(s) and nitrogen-containing reactant(s) with other components of the binder composition, wherein “further reaction” includes deleterious polymerization and/or cross-linking of the solution components, and further prevents or reduces undesirable viscosity increases of the binder composition during storage and/or shipping under both ideal and non-optimal shipping and/or storage conditions. Subsequent heating, notably during curing of the binder composition, may be used to separate oxygen based components such as carbon dioxide from the binder composition and thus allow the reactants previously stabilized for storage to participate in curing of the binder composition.


Carbon dioxide (CO2) may be injected into the binder composition at a concentration capable of reacting approximately stoichiometrically with the nitrogen containing reactant(s), notably following reaction between the reducing sugar reactant(s) and nitrogen-containing reactant(s) to form curable reaction product(s) of the reducing sugar reactant(s) and nitrogen-containing reactant(s). Carbon dioxide (CO2) may be injected to produce a concentration of about 0.5-5% by weight with respect to the binder composition, notably about 1-2% by weight. The carbon dioxide (CO2) may be introduced to the binder composition using a stainless steel needle; a nano-, micro- or mini-bubbler system; or any bubbler/aerator capable of introducing CO2 into the binder composition.


The binder composition is preferably water soluble; it may have a water-solubility at ambient conditions (e.g. at approximately 20° C. and 1 atm) of 100 g/l or more, 150 g/l or more, 200 g/l or more, 250 g/l or more, 300 g/l or more, 400 g/l or more, 500 g/l or more, and 600 g/l or more.


Preferably the viscosity of the binder composition in solution resists increases by more than 1000 cP when left to stand at ambient temperatures, i.e. at temperatures of about 20-25° C., fora time period of 12, 24, 48, 72 or 96 hours. In further embodiments, the viscosity of the aqueous solution advantageously does not increase by more than 10 000 cP over a time period of 7, 10, 12, 14, 21, 28, 30, 60 or 90 days. According to further embodiments, the amount by which the viscosity of a 70 wt. % aqueous solution of the disclosed composition increases within the first 12 hours when left to stand at 20° C. does not exceed 500, 400, 300, 250, 200, 150, 100, 50, 10 and 5 centiPoise (cP) or less. Preferably, a 70 wt. % aqueous solution of the binder composition does not increase in viscosity by more than 1000 cP within the first 48 hours after its preparation, and notably does not increase by more than 2000 cP within two weeks after its preparation. Excessive viscosity increases for an aqueous solution of the binder composition may result in “gelling,” which may render the binder composition unusable.


In some preferred embodiments, the binder composition allows for one or more reactions of the reducing sugar reactant(s) and nitrogen-containing reactant(s) and/or curable reaction product(s) of reducing sugar reactant(s) and nitrogen-containing reactant(s) of the binder composition following the evolution, removal and/or degassing of carbon dioxide. Accordingly, such reactions allow for further reactions with one or more crosslinkers for producing a polymeric binder. For example, this polymeric binder may contain high molecular weight polymers, e.g. melanoidins, as essentially water insoluble Maillard reaction products. For example, the binder composition may be prepared by mixing a reducing sugar reactant with a nitrogen containing reactant which consists of or comprises hexamethylenediamine (HMDA) and/or 4-(aminomethyl)-1,8-octanediamine (AMOD) and adding CO2. Subsequently, further nitrogen containing reactant, for example further hexamethylenediamine and/or 4-(aminomethyl)-1,8-octanediamine (AMOD), may be added to the binder composition to achieve the high grade of polymerization required in the respective polymerized application.


Preparation of the binder composition may comprise: i) providing the reducing sugar reactant(s); (ii) providing the nitrogen containing reactant(s); (iii) providing carbon dioxide; (iv) mixing in a solvent the reducing sugar reactant(s) and the nitrogen containing reactant(s); (v) cooling, notably at room temperature; and (vi) bubbling carbon dioxide into the mixture obtained in step (iv).


The carbon dioxide may be introduced via direct injection, e.g. through bubbling, into the mixture, notably at a rate of about 0.5 to 50 wt. % based on the total weight of the binder composition, or at a rate of about 1 to about 45 wt. %, about 1 to about 40 wt. %, about 1 to about 35 wt. %, about 1 to about 30 wt. %, about 1 to about 25 wt. %, about 1 to about 20 wt. %, about 1 to about 15 wt. %, about 1 to about 10 wt. %, and about 1 to about 5 wt. %. In alternative embodiments, carbonic acid or “soda water” may be utilized as a source of carbon dioxide to provide all or part of the carbon dioxide for the disclosed binder composition. A preformed carbamate compound produced via reaction with the at least one nitrogen containing reactant(s) may be used.


The invention will now be described by way of example only with reference to the accompanying drawing of which:



FIG. 1 shows 4-(aminomethyl)-1,8-octanediamine;



FIG. 2 shows an example of TPTA triprimary triamine (“AMOD”);



FIG. 3 shows results of a thermal stability study for binder compositions; and



FIG. 4 shows results of a temporal viscosity study.



FIG. 2 illustrates a TPTA triprimary triamine having three primary amines A, B, D with spacer groups which consist of carbon chains between each of its three primary amines. Each carbon atom is numbered to facilitate the explanation below.


The spacer group between primary amines A and B:






    • has a spacer length of 7, i.e. carbon atoms 1, 2, 3, 4, 5, 6, 7 which together form the shortest chain of covalently bonded polyvalent atoms between primary amines A and B (the carbon atoms of the two branched chains 8, 9 and 10, 11 do not form part of the spacer length;

    • has 11 polyvalent atoms, ie carbon atoms 1, 2, 3, 4, 5, 6, 7, 8, 9, 10 and 11 (the carbon atoms 12, 13, 14, 15, 16 do not form part of the spacer group between A and B as they form a chain which connects the third primary amine D to the molecule).


      The spacer group between primary amines A and D:

    • has a spacer length of 10, i.e. carbon atoms 1, 2, 3, 4, 5, 12, 13, 14, 15, 16;

    • has 14 polyvalent atoms, i.e. carbon atoms 1, 2, 3, 4, 5, 8, 9, 10, 11, 12, 13, 14, 15, 16.


      The spacer group between primary amines B and D:

    • has a spacer length of 8, i.e. carbon atoms 7, 6, 5, 12, 13, 14, 15, 16;

    • has 10 polyvalent atoms, ie carbon atoms 7, 6, 5, 12, 13, 14, 15, 16, 10, 11 (the chain of carbon atoms 4, 3, 2, 1, 8, 9 does not form part of the spacer group between B and D as this form a chain which connects the other primary amine A to the molecule.


      The total number of polyvalent atoms in the molecule is 19, i.e. carbon atoms 1 to 16 and the 3 nitrogen atoms of the 3 primary amines A, B and D.





EXAMPLE 1: BINDER COMPOSITION STABILITY TESTING

An aqueous binder composition (“H3823”—a 38 wt. % binder solids solution obtained by combining, by dry weight, 23 wt. % hexamethylenediamine (HMDA) as the nitrogen containing reactant and HFCS (high fructose corn syrup) as the reducing sugar reactant) was produced and observed to have an initial viscosity of about 15 centiPoise (cP). The initial sample was then divided into two (2) H3823 aliquots, which are exemplified as “Unshaken” (Series 2) and “Shaken” (Series 1) in FIG. 3. Both samples were subjected to approximately ambient temperature and pressure conditions, i.e. a temperature of about 68-70° F. and a pressure of approximately 1 atmosphere (atm). The first sample (“Shaken”) was sealed in a first storage vessel and unshaken, during which the temperature of the composition increased by about 7° F. (to a temperature of about 77° F.) over room temperature and remained at this elevated temperature for about five (5) days (about 120 hours). Following a period of about seven (7) days (about 168 hours), the first sample cooled to about 3° F. above room temperature.


The second sample (“Shaken”) was shaken three times a day, at a frequency of one shake approximately every 2-3 hours, on weekdays (Monday-Friday, unshaken on Saturday-Sunday). The temperature of the “Shaken” sample was observed to increase by about 10° F. over room temperature (to a temperature of about 80° F.) and remained at the elevated temperature for about seven (7) days (about 168 hours) and was observed to cool down to room temperature (about 70° F.) at a significantly slower rate. However, both the “Unshaken” and “Shaken” were found to comprise very similar viscosity values (about 18.5 cP) following the seven (7) day trial period. Additionally, both samples (“Shaken” and “Unshaken”) were observed to resist thermal damage when maintained at solution temperatures at or below 80° F.


EXAMPLE 2. ADDITIONAL THERMAL STABILITY MEASUREMENTS FOR BINDER COMPOSITIONS

In a trial separate from that described for the H3823 composition in Example 1, it was observed that a quart of the unmodified tanker batch gelled following overnight storage (a time period of about 10-12 hours) at a temperature of about 102° F. In an effort to extend usability and shelf life for the claimed composition, a separate sample was taken and time-dependent viscosity values were measured at ambient temperature and pressure conditions (about 20-25° F. and about 1 atm) over about 25 days (about 600 hours):












TABLE 1







Age of Sample (Days)
Viscosity (cP)



















1
13



3
14



7
17



13
18.5



18
24



21
34



22
55



23
120



25
Gel










Under ambient conditions, the sample exhibited a commercially viable product shelf life of greater than 3 weeks, with disadvantageous product gelling occurring around 3.5-4 weeks (about 600 to about 684 hours). In a follow-up trial, an additional time dependent assay was performed on an H3823 sample initially maintained under ambient conditions. As shown in Table 2, separate aliquots of the sample were then exposed to 1) a temperature of 98° F. after two days (about 48 hours) for a time period of about 48 hours; and 2) a temperature of 87° F. after four days (about 96 hours) for a time period of about 24 hours:











TABLE 2





Sample History
Exposure Time
Viscosity (cP)







Maintained at room temperature
24 hours
17 cP


for five days (~120 hours)


Exposed to 98° F. after two days
48 hours
Gel


(~48 hours)


Exposed to 87° F. after four days
24 hours
16 cP


(~96 hours)









In an effort to achieve enhanced thermal/temporal stability, a 50 wt. % binder solids binder composition was prepared by mixing, by dry weight, 23 wt. % hexamethylenediamine (HMDA) and 77 wt. % high fructose corn syrup (described herein as “H5023”) and evaluated for shelf life stability as a function of compositional pH. A single aliquot, comprising a pH of about 11.3, was not treated with carbon dioxide (CO2), while five aliquots were subjected to bubbling with sufficient volumes of CO2 to achieve the pH levels disclosed in Table 3 below:










TABLE 3





Sample pH
Observed Physical States/Measured Viscosity







11.3 (no CO2 treatment)
Liquid (Day 18); Gel (Day 19)


9.4 (CO2 treatment)
Liquid (Day 19); 190 cP (Day 110)


8.6 (CO2 treatment)
Liquid (Day 19); 60 cP (Day 110)


8.3 (CO2 treatment)
Liquid (Day 19); 52 cP (Day 110)


8.1 (CO2 treatment)
Liquid (Day 19); 50 cP (Day 110)


8.0 (CO2 treatment)
31 cP (19 Days); 50 cP (Day 110)









As shown in Table 3, the H5023 sample (comprising 50% binder solids) exhibited a shelf life stability of at least about 110 days, after which no further measurements were recorded. It was observed that the CO2 treated samples (pH of 9.4, 8.6, 8.3, 8.1, and 8.0) exhibited sufficient thermal stability and characteristics associated with sufficient storage/shelf life stability, as well as stability during the transportation and/or processing of the material. For instance, the pH 8.0, CO2 treated aliquot had an initial viscosity of about 25 cP, a viscosity of about 31 cP after 19 days, and a viscosity of about 50 cP after 110 days.


A duplicate H5023 sample was then created and divided into three (3) separate aliquots for determining compositional viscosity following (1) no treatment with CO2; (2) CO2 treatment to produce a compositional pH of 9.33; and (3) CO2 treatment to produce a compositional pH of 8.22. The resulting viscosity values as a function of time and pH are provided in Table 4:












TABLE 4





Time Elapsed
No CO2
CO2 Treatment
CO2 Treatment


(hours)
Treatment
pH = 9.33
pH = 8.22


















24
22
23
25


120
42
28
30









Additional H5023 samples were treated with CO2 to produce the compositional pH values described in Table 5 (below), where commercial viability/stability was observed to be at or greater than about 90 days at pH values of 8.6 and 8.2:














TABLE 5









Viscosity
Estimated Usability



pH
Days
(cP)
of Material (days)





















11.2
19
Gel
15



9.3
64
138
60+



8.6
80
50
90+



8.2
64
36
90+










EXAMPLE 3. BINDER COMPOSITIONS COMPRISING INCREASED SOLIDS/NITROGEN-CONTAINING REACTANT CONCENTRATIONS

In further efforts to enhance commercial properties two (2) quarts of a 70 wt. % binder solids binder composition were prepared by combining, by dry weight, 30 wt. % hexamethylenediamine (HMDA) and 70 wt. % high fructose corn syrup (described herein as “H7030”). The results for various (CO2 treated and untreated) binder samples as a function of pH and time are shown in FIG. 2.


An additional sample comprising 70 wt. % binder solids prepared by combing, by dry weight, 23 wt. % hexamethylenediamine (HMDA) and 70 wt. % high fructose corn syrup (described herein as “H7023”) was produced and evaluated. This sample (comprising a decreased concentration of polyamine) was disadvantageously observed to gel to an increased degree and/or at an enhanced rate versus the H7030 composition, which suggests that the additional polyamine concentration comprising the H7030 sample may provide thermal and/or temporal stability under certain processing, transporting and/or storage conditions versus a sample with a decreased polyamine concentration, e.g. H7023.


EXAMPLE 4. USER OF BINDER COMPOSITION FOR ENHANCING CORRUGATED BOARD/CARDBOARD PERFORMANCE

In an effort to improve the performance of starch comprising, corrugated cardboard articles and manufacturing processes for producing these articles, a 50 wt. % solids composition was prepared by combining, by dry weight, and 19 wt. % 4-(aminomethyl)-1,8-octanediamine (AMOD)—commercially available as Hexatran™ from Ascend Performance Materials and 81 wt. % high fructose corn syrup, hereinafter referred to as “T5019,” was prepared. It was observed that this composition was stable under ambient temperature/pressure conditions on a benchtop for at least about four (4) months. A batch of T5019 was then treated with a sufficient concentration of CO2 to produce a compositional pH of about 8.8. The resulting composition is hereinafter described as “MaxxLink® Gold”.


The MaxxLink® Gold composition was incorporated in a corrugated produce cardboard box at a concentration of 2.0% (weight/weight) as a waterproofing agent for starch based compositions and compared to a corrugated produce cardboard box comprising MaxxLink® XL-5000, a general purpose, ketone formaldehyde based resin used as a waterproofing agent for starch based compositions (commercially available from MCTRON™ Technologies, Greenville, SC, USA). The performance of the corrugated produce cardboard box was measured via a pin adhesion, alternatively referred to as a “wet pin adhesion” or simply “wet pins” test (see, for example, 1) https://imisrise.tappi.org/TAPPI/Products/01/T/0104T845.aspx; and 2) https://www.westpak.com/page/material-analysis/material-analysis-pin-adhesion). In certain embodiments, an ideal “wet pins” quantitative performance value for the disclosed trial is in the range of about 2 to about 6, including about 4 to about 5. The results are shown in Table 6 below:












TABLE 6







MaxxLink XL-5000
MaxxLink Gold




















Board Caliper
0.27
0.27



Edge Crush
71.4
72.4



DB Dry Pins
54.9
55.8



SF Dry Pins
61.8
66.6



DB Wet Pins
3.08
3.33



SF Wet Pins
4.29
2.15










EXAMPLE 5. ALTERNATIVE BINDER

In additional trials, the performance of the disclosed binder was evaluated in comparison with N-methylolacrylamide (N-MA; molecular formula: C4H7NO2) and formaldehyde containing formulations. N-MA is used commercially in adhesives, binders, coatings and resins, including its use in latex based compositions. Commercial articles comprising N-MA may comprise significant concentrations, e.g. 200 ppm and greater, of formaldehyde, while generating and emitting significant levels of formaldehyde during manufacturing processes associated with N-MA.


As a potential substitute for a binder composition comprising N-MA and a PVAc resin, a binder comprising Maillard reactants (“H5023” as described herein) and polyvinyl acetate (PVAc) was prepared and compared to 1) an N-MA/PVAc binder; and 2) unmodified PVAc. Physicochemical performance was evaluated, specifically heat (via a “hot stiffness” test, a subjective measure of fabric cutting ease) and solvent resistance, wherein the weight fraction of the composition that dissolves in acetone after an hour is measured (wherein increased percentages of insoluble correlate to increased solvent resistance). As shown in Table 7 below, the Maillard reactants modified PVAc binder demonstrated comparable performance to the N-MA/PVAc binder, as well as improved solvent resistance versus the PVAc control. In addition, the Maillard reactants modified PVAc binder beneficially demonstrates a significant reduction in formaldehyde production as measured by the American Association of Textile Colorants and Chemists (AATCC) Test Method TM112 (https://www.aatcc.org/test/methods/).













TABLE 7







N-MA Modified
Unmodified
Maillard reactants



PVAc
PVAc
Modified PVAc



















Percentage of
91.3
68.4
93.8


Insolubles in


Acetone


Hot Stiffness
Very Good
Poor
Very Good


Free Formaldehyde,
513 ppm
<20 ppm
<20 ppm


wet









EXAMPLE 6. USE OF CARBONIC ACID/CO2 FOR IMPROVING BINDER PERFORMANCE

In additional experiments, a 54% (final) solids binder was prepared using a pre-mix of water and a H5223 binder solution (52% (initial) binder solids and 25% hexamethylenediamine (HMDA)). A sufficient volume of carbon dioxide (CO2) was then bubbled through the solution to a produce a final CO2 concentration of 2%, which facilitates the partial neutralize of the final solution. This pre-mix was removed from the reactor, mixed with a 70% (volume/volume) aqueous solution of high fructose corn syrup (HFCS), and re-introduced to the reactor, which was maintained at a temperature below 30° C. The resulting binder demonstrated a shelf-life under ambient temperature and pressure conditions of about 90 days, and is highly reactive as a thermosettable binder when cured on a production line at temperatures above 150° C.











TABLE 8





Component
Wet Weight Percentage
Dry Weight Percentage

















Water
25.2%
0.0%


HMDA (70%)
16.0%
11.2%


CO2
4.6%
4.6%


HFCS (71%)
54.2%
38.4%


Total
100.0%
54.2%









In alternative embodiments, latex may further be utilized to enhance the performance of articles such as corrugated cardboard, for applications where performance issues including but not limited to binder failure and low temperature pins are observed.

Claims
  • 1. A method of manufacturing a composite product comprising: preparing a binder composition in the form of an aqueous solution, which comprises combining: i) Maillard reactants; ii) a component selected from a resin, reactants of the resin, and a combination thereof; and water; wherein the i) Maillard reactants are: a combination of one or more reducing sugar reactants and one or more nitrogen-containing reactants; a curable reaction product of the one or more reducing sugar reactants and the one or more nitrogen-containing reactants; or a combination of the one or more reducing sugar reactants, the one or more nitrogen-containing reactants, and the curable reaction product; and stabilizing the i) Maillard reactants before, during or after said combining by introducing carbon dioxide; wherein the carbon dioxide reacts with the one or more nitrogen-containing reactants and/or the curable reaction product to form one or more carbamate compounds;applying the binder composition to non-assembled or loosely-assembled matter to provide resinated matter;arranging the resinated matter to provide loosely arranged resinated matter; andsubjecting the loosely arranged resinated matter to heat and/or pressure to cure the binder composition and to form the composite product.
  • 2. A method in accordance with claim 1, wherein the resin is selected from: latex resin, formaldehyde resin, melamine formaldehyde resin, melamine urea formaldehyde resin, urea formaldehyde resin, phenol formaldehyde resin, melamine phenol formaldehyde resin, ketone formaldehyde resin, carboxymethyl-cellulose-based resin, starch-based resin, polyurethane resin, polyurea and polyurethane hybrid resin, rubber resin, diallyl-phthalate resin, epoxy resin, epoxy novolac resin, benzoxazine resin, benzoxazine resin hybridised with epoxy and/or phenolic resin, polyimide resin, bismaleimide resin, cyanate ester resin, polycyanurate resin, furan resin, silicone resin, thiolyte resin, vinyl ester resin, and combinations thereof.
  • 3. A method in accordance with claim 1, wherein the resin is selected from latex resin and starch-based resin.
  • 4. A method in accordance with claim 1, wherein the binder composition comprises at least 50 wt % dry weight of ii) the component selected from a resin, reactants of the resin, and a combination thereof.
  • 5. A method in accordance with claim 1, wherein the one or more reducing sugar reactants accounts for at least 15 wt % dry weight of the i) Maillard reactants, and the one or more nitrogen-containing reactants accounts for at least 2 wt % dry weight of the i) Maillard reactants.
  • 6. A method in accordance with claim 1, wherein the one or more nitrogen-containing reactants is selected from: substituted or unsubstituted inorganic or organic amines, ammonia, inorganic or organic ammonium salts, and combinations thereof.
  • 7. A method in accordance with claim 6, wherein the substituted or unsubstituted inorganic or organic amines are selected from: organic amines comprising at least one primary amine, salts of an organic amine comprising at least one primary amine, polyamines, polyprimary polyamines and combinations thereof; and wherein the inorganic or organic ammonium salts are selected from: an ammonium sulfate, an ammonium phosphate, an ammonium citrate, and combinations thereof.
  • 8. A method in accordance with claim 1, wherein the one or more nitrogen-containing reactants is selected from: diamines, di-primary diamines, HMDA, triamines, triprimary triamines, TPTA triprimary triamine(s), 4-(aminomethyl)-1,8-octanediamine, and combinations thereof.
  • 9. A method in accordance with claim 1, wherein the i) Maillard reactants are: the curable reaction product of the one or more reducing sugar reactants and the one or more nitrogen-containing reactants; or a combination of the one or more reducing sugar reactants, the one or more nitrogen-containing reactants, and the curable reaction product.
  • 10. A method in accordance with claim 1, wherein the i) Maillard reactants are: the curable reaction product of the one or more reducing sugar reactants and the one or more nitrogen-containing reactants.
  • 11. A method in accordance with claim 1, wherein preparation of the binder composition comprises: a) forming a solution by combining the one or more reducing sugar reactants, the one or more nitrogen-containing reactants, and water;b) reacting the one or more reducing sugar reactants and the one or more nitrogen-containing reactants to provide a solution of the i) Maillard reactants, wherein the i) Maillard reactants are the curable reaction product of the one or more reducing sugar reactants and the one or more nitrogen-containing reactants; or a combination of the one or more reducing sugar reactants, the one or more nitrogen-containing reactants, and the curable reaction product;c) subsequently stabilizing the i) Maillard reactants by passing carbon dioxide through the solution; andd) subsequently combining the solution of stabilized i) Maillard reactants with ii) the component selected from a resin, reactants of the resin, and a combination thereof.
  • 12. A method in accordance with claim 1, wherein the composite product is a corrugated cardboard article comprising fluted corrugated sheets and a planar linerboard; wherein the binder composition bonds corrugations of the fluted corrugated sheets to the planar linerboard.
Priority Claims (1)
Number Date Country Kind
1804908 Mar 2018 GB national
CROSS-REFERENCE TO RELATED APPLICATIONS

This application is a U.S. national counterpart application of International Application Serial No. PCT/EP2019/057803, filed Mar. 27, 2019, under 35 U.S.C. § 371, which claims priority to GB Application Serial No. 1804908.0, filed Mar. 27, 2018, and to U.S. Application Ser. No. 62/662,494, filed Apr. 25, 2018, the disclosures of which are hereby incorporated herein by reference.

PCT Information
Filing Document Filing Date Country Kind
PCT/EP2019/057803 3/27/2019 WO
Publishing Document Publishing Date Country Kind
WO2019/185762 10/3/2019 WO A
US Referenced Citations (476)
Number Name Date Kind
1801052 Meigs Apr 1931 A
1801053 Meigs Apr 1931 A
1886353 Novotny et al. Nov 1932 A
1902948 Castle Mar 1933 A
1964263 Krenke Jun 1934 A
2198874 Leighton Apr 1940 A
2215825 Wallace et al. Sep 1940 A
2261295 Schlack Nov 1941 A
2362086 Eastes et al. Nov 1944 A
2371990 Hanford Mar 1945 A
2392105 Sussman Jan 1946 A
2442989 Sussman Jun 1948 A
2500665 Courtright Mar 1950 A
2518956 Sussman Aug 1950 A
2875073 Gogek Feb 1959 A
2894920 Ramos Jul 1959 A
2965504 Gogek Dec 1960 A
3038462 Bohdan Jun 1962 A
3138473 Floyd et al. Jun 1964 A
3222243 Gaston et al. Dec 1965 A
3231349 Stalego Jan 1966 A
3232821 Banks et al. Feb 1966 A
3297419 Eyre, Jr. Jan 1967 A
3513001 Woodhead et al. May 1970 A
3551365 Matalon Dec 1970 A
3784408 Jaffe et al. Jan 1974 A
3791807 Etzel et al. Feb 1974 A
3802897 Bovier et al. Apr 1974 A
3809664 Burr et al. May 1974 A
3826767 Hoover et al. Jul 1974 A
3856606 Fan et al. Dec 1974 A
3867119 Takeo et al. Feb 1975 A
3907724 Higginbottom Sep 1975 A
3911048 Nistri et al. Oct 1975 A
3919134 Higginbottom Nov 1975 A
3922466 Bell et al. Nov 1975 A
3955031 Jones et al. May 1976 A
3956204 Higginbottom May 1976 A
3961081 McKenzie Jun 1976 A
3971807 Brack Jul 1976 A
4014726 Fargo Mar 1977 A
4028290 Reid Jun 1977 A
4048127 Gibbons et al. Sep 1977 A
4054713 Sakaguchi et al. Oct 1977 A
4085076 Gibbons et al. Apr 1978 A
4097427 Aitken et al. Jun 1978 A
4107379 Stofko Aug 1978 A
4109057 Nakamura et al. Aug 1978 A
4144027 Habib Mar 1979 A
4148765 Nelson Apr 1979 A
4183997 Stofko Jan 1980 A
4184986 Krasnobajew et al. Jan 1980 A
4186053 Krasnobajew et al. Jan 1980 A
4201247 Shannon May 1980 A
4201857 Krasnobajew et al. May 1980 A
4217414 Walon Aug 1980 A
4233432 Curtis, Jr. Nov 1980 A
4246367 Curtis, Jr. Jan 1981 A
4259190 Fahey Mar 1981 A
4265963 Matalon May 1981 A
4278573 Tessler Jul 1981 A
4296173 Fahey Oct 1981 A
4301310 Wagner Nov 1981 A
4310585 Shannon Jan 1982 A
4322523 Wagner Mar 1982 A
4330443 Rankin May 1982 A
4333484 Keritsis Jun 1982 A
4357194 Stofko Nov 1982 A
4361588 Herz Nov 1982 A
4379101 Smith Apr 1983 A
4393019 Geimer Jul 1983 A
4396430 Matalon Aug 1983 A
4400496 Butler et al. Aug 1983 A
4464523 Neigel et al. Aug 1984 A
4506684 Keritsis Mar 1985 A
4520143 Jellinek May 1985 A
4524164 Viswanathan et al. Jun 1985 A
4631226 Jellinek Dec 1986 A
4654259 Stofko Mar 1987 A
4668716 Pepe et al. May 1987 A
4692478 Viswanathan et al. Sep 1987 A
4714727 Hume, III Dec 1987 A
4720295 Bronshtein Jan 1988 A
4734996 Kim et al. Apr 1988 A
4754056 Ansel et al. Jun 1988 A
4761184 Markessini Aug 1988 A
4780339 Lacourse et al. Oct 1988 A
4828643 Newman et al. May 1989 A
4845162 Schmitt et al. Jul 1989 A
4906237 Johansson et al. Mar 1990 A
4912147 Pfoehler et al. Mar 1990 A
4918861 Carpenter et al. Apr 1990 A
4923980 Blomberg May 1990 A
4950444 Deboufie et al. Aug 1990 A
4988780 Das et al. Jan 1991 A
4992519 Mukherjee Feb 1991 A
5001202 Denis et al. Mar 1991 A
5013405 Izard May 1991 A
5032431 Conner et al. Jul 1991 A
5037930 Shih Aug 1991 A
5041595 Yang et al. Aug 1991 A
5089342 Dhein et al. Feb 1992 A
5095054 Lay et al. Mar 1992 A
5106615 Dikstein Apr 1992 A
5114004 Isono et al. May 1992 A
5123949 Thiessen Jun 1992 A
5124369 Vandichel et al. Jun 1992 A
5128407 Layton et al. Jul 1992 A
5143582 Arkens et al. Sep 1992 A
5151465 Le-Khac Sep 1992 A
5167738 Bichot et al. Dec 1992 A
5198492 Stack Mar 1993 A
5217741 Kawachi et al. Jun 1993 A
5218048 Abe et al. Jun 1993 A
5240498 Matalon et al. Aug 1993 A
5244474 Lorcks et al. Sep 1993 A
5278222 Stack Jan 1994 A
5300144 Adams Apr 1994 A
5300192 Hansen et al. Apr 1994 A
5308896 Hansen et al. May 1994 A
5318990 Strauss Jun 1994 A
5336753 Jung et al. Aug 1994 A
5336755 Pape Aug 1994 A
5336766 Koga et al. Aug 1994 A
5340868 Strauss et al. Aug 1994 A
5352480 Hansen et al. Oct 1994 A
5367849 Bullock Nov 1994 A
5371194 Ferretti Dec 1994 A
5387665 Misawa et al. Feb 1995 A
5389716 Graves Feb 1995 A
5393849 Srinivasan et al. Feb 1995 A
5416139 Zeiszler May 1995 A
5421838 Gosset et al. Jun 1995 A
5424418 Duflot Jun 1995 A
5434233 Kiely et al. Jul 1995 A
5447977 Hansen et al. Sep 1995 A
5470843 Stahl et al. Nov 1995 A
5480973 Goodlad et al. Jan 1996 A
5492756 Seale et al. Feb 1996 A
5498662 Tanaka et al. Mar 1996 A
5503920 Alkire et al. Apr 1996 A
5534612 Taylor et al. Jul 1996 A
5536766 Seyffer et al. Jul 1996 A
5538783 Hansen et al. Jul 1996 A
5543215 Hansen et al. Aug 1996 A
5545279 Hall et al. Aug 1996 A
5547541 Hansen et al. Aug 1996 A
5547745 Hansen et al. Aug 1996 A
5550189 Qin et al. Aug 1996 A
5554730 Woiszwillo et al. Sep 1996 A
5562740 Cook et al. Oct 1996 A
5571618 Hansen et al. Nov 1996 A
5578678 Hartmann et al. Nov 1996 A
5580856 Prestrelski et al. Dec 1996 A
5582682 Ferretti Dec 1996 A
5583193 Aravindakshan et al. Dec 1996 A
5589256 Hansen et al. Dec 1996 A
5589536 Golino et al. Dec 1996 A
5607759 Hansen et al. Mar 1997 A
5608011 Eck et al. Mar 1997 A
5609727 Hansen et al. Mar 1997 A
5614570 Hansen et al. Mar 1997 A
5620940 Birbara et al. Apr 1997 A
5621026 Tanaka et al. Apr 1997 A
5633298 Arfaei et al. May 1997 A
5641561 Hansen et al. Jun 1997 A
5643978 Darwin et al. Jul 1997 A
5645756 Dubin et al. Jul 1997 A
5660904 Andersen et al. Aug 1997 A
5661213 Arkens et al. Aug 1997 A
5670585 Taylor et al. Sep 1997 A
5672418 Hansen et al. Sep 1997 A
5672659 Shalaby et al. Sep 1997 A
5690715 Schiwek Nov 1997 A
5691060 Levy Nov 1997 A
5693411 Hansen et al. Dec 1997 A
5719092 Arrington Feb 1998 A
5719228 Taylor et al. Feb 1998 A
5733624 Syme et al. Mar 1998 A
5756580 Natori et al. May 1998 A
5763524 Arkens et al. Jun 1998 A
5788243 Harshaw et al. Aug 1998 A
5788423 Perkins Aug 1998 A
5807364 Hansen Sep 1998 A
5855987 Margel et al. Jan 1999 A
5863985 Shalaby et al. Jan 1999 A
5885337 Nohr et al. Mar 1999 A
5895804 Lee et al. Apr 1999 A
5905115 Luitjes et al. May 1999 A
5916503 Rettenbacher Jun 1999 A
5919528 Huijs et al. Jul 1999 A
5919831 Philipp Jul 1999 A
5922403 Tecle Jul 1999 A
5925722 Exner et al. Jul 1999 A
5929184 Holmes-Farley et al. Jul 1999 A
5929196 Kissel Jul 1999 A
5932344 Ikemoto et al. Aug 1999 A
5932665 DePorter et al. Aug 1999 A
5932689 Arkens et al. Aug 1999 A
5942123 McArdle Aug 1999 A
5954869 Elfersy et al. Sep 1999 A
5977224 Cheung et al. Nov 1999 A
5977232 Arkens et al. Nov 1999 A
5981719 Woiszwillo et al. Nov 1999 A
5983586 Berdan, II et al. Nov 1999 A
5990216 Cai et al. Nov 1999 A
5993709 Bonomo et al. Nov 1999 A
6022615 Rettenbacher Feb 2000 A
6067821 Jackson et al. May 2000 A
6071549 Hansen Jun 2000 A
6071994 Hummerich et al. Jun 2000 A
6072086 James et al. Jun 2000 A
6077883 Taylor et al. Jun 2000 A
6090925 Woiszwillo et al. Jul 2000 A
6114033 Ikemoto et al. Sep 2000 A
6114464 Reck et al. Sep 2000 A
6133347 Vickers, Jr. et al. Oct 2000 A
6136916 Arkens et al. Oct 2000 A
6139619 Zaretskiy et al. Oct 2000 A
6143243 Gershun et al. Nov 2000 A
6171444 Nigam Jan 2001 B1
6171654 Salsman et al. Jan 2001 B1
6180037 Andersen et al. Jan 2001 B1
6194512 Chen et al. Feb 2001 B1
6210472 Kwan et al. Apr 2001 B1
6221958 Shalaby et al. Apr 2001 B1
6221973 Arkens et al. Apr 2001 B1
6231721 Quick et al. May 2001 B1
6274661 Chen et al. Aug 2001 B1
6281298 Papsin, Jr. Aug 2001 B1
6299677 Johnson et al. Oct 2001 B1
6299936 Reck et al. Oct 2001 B1
6307732 Tsubaki et al. Oct 2001 B1
6310227 Sarama et al. Oct 2001 B1
6313102 Colaco et al. Nov 2001 B1
6319683 James et al. Nov 2001 B1
6331350 Taylor et al. Dec 2001 B1
6331513 Zaid et al. Dec 2001 B1
6340411 Hansen et al. Jan 2002 B1
6348530 Reck et al. Feb 2002 B1
6365079 Winkler et al. Apr 2002 B1
6372077 Tecle Apr 2002 B1
6379739 Formanek et al. Apr 2002 B1
6379814 Dupre et al. Apr 2002 B1
6395856 Petty et al. May 2002 B1
6403665 Sieker et al. Jun 2002 B1
6407225 Mang et al. Jun 2002 B1
6410036 De Rosa et al. Jun 2002 B1
6440204 Rogols et al. Aug 2002 B1
6441122 DeMott et al. Aug 2002 B1
6461553 Hansen et al. Oct 2002 B1
6468442 Bytnar Oct 2002 B2
6468730 Fujiwara et al. Oct 2002 B2
6469120 Elfersy et al. Oct 2002 B1
6475552 Shah et al. Nov 2002 B1
6482875 Lorenz et al. Nov 2002 B2
6495656 Haile et al. Dec 2002 B1
6521339 Hansen et al. Feb 2003 B1
6525009 Sachdev et al. Feb 2003 B2
6538057 Wildburg et al. Mar 2003 B1
6547867 Rogols et al. Apr 2003 B2
6555616 Helbing et al. Apr 2003 B1
6559302 Shah et al. May 2003 B1
6562267 Hansen et al. May 2003 B1
6596103 Hansen et al. Jul 2003 B1
6613378 Erhan et al. Sep 2003 B1
6638882 Helbing et al. Oct 2003 B1
6638884 Quick et al. Oct 2003 B2
6699945 Chen et al. Mar 2004 B1
6706853 Stanssens et al. Mar 2004 B1
6719862 Quick et al. Apr 2004 B2
6730730 Hansen et al. May 2004 B1
6753361 Kroner et al. Jun 2004 B2
6818694 Hindi et al. Nov 2004 B2
6821547 Shah et al. Nov 2004 B2
6852247 Bytnar Feb 2005 B2
6858074 Anderson et al. Feb 2005 B2
6861495 Barsotti et al. Mar 2005 B2
6864044 Ishikawa et al. Mar 2005 B2
6878800 Husemoen et al. Apr 2005 B2
6884849 Chen et al. Apr 2005 B2
6955844 Tagge et al. Oct 2005 B2
6962714 Hei et al. Nov 2005 B2
6989171 Portman Jan 2006 B2
6992203 Trusovs Jan 2006 B2
7018490 Hansen et al. Mar 2006 B2
7029717 Ojima et al. Apr 2006 B1
7067579 Taylor et al. Jun 2006 B2
7083831 Koch et al. Aug 2006 B1
7090745 Beckman et al. Aug 2006 B2
7141626 Rodrigues et al. Nov 2006 B2
7144474 Hansen et al. Dec 2006 B1
7195792 Boston et al. Mar 2007 B2
7201778 Smith et al. Apr 2007 B2
7201825 Dezutter et al. Apr 2007 B2
7202326 Kuroda et al. Apr 2007 B2
7241487 Taylor et al. Jul 2007 B2
7458235 Beaufils et al. Dec 2008 B2
7514027 Horres et al. Apr 2009 B2
7655711 Swift et al. Feb 2010 B2
7772347 Swift et al. Aug 2010 B2
7795354 Srinivasan et al. Sep 2010 B2
7803879 Srinivasan et al. Sep 2010 B2
7807771 Swift et al. Oct 2010 B2
7842382 Helbing Nov 2010 B2
7854980 Jackson et al. Dec 2010 B2
7883693 Sehl et al. Feb 2011 B2
7888445 Swift et al. Feb 2011 B2
7947765 Swift et al. May 2011 B2
8114210 Hampson et al. Feb 2012 B2
8182648 Swift et al. May 2012 B2
8211923 Wagner et al. Jul 2012 B2
8372900 Shooshtari et al. Feb 2013 B2
8377564 Shooshtari et al. Feb 2013 B2
8501838 Jackson et al. Aug 2013 B2
8680224 Zhang et al. Mar 2014 B2
8691934 Helbing et al. Apr 2014 B2
8900495 Pacorel et al. Dec 2014 B2
20010017427 Rosthauser et al. Aug 2001 A1
20010046824 Nigam Nov 2001 A1
20020000100 Burg et al. Jan 2002 A1
20020025435 Hansen et al. Feb 2002 A1
20020026025 Kuo et al. Feb 2002 A1
20020028857 Holy Mar 2002 A1
20020032253 Lorenz et al. Mar 2002 A1
20020042473 Trollsas et al. Apr 2002 A1
20020091185 Taylor et al. Jul 2002 A1
20020096278 Foster et al. Jul 2002 A1
20020123598 Sieker et al. Sep 2002 A1
20020130439 Kroner et al. Sep 2002 A1
20020161108 Schultz et al. Oct 2002 A1
20020197352 Portman Dec 2002 A1
20030005857 Minami et al. Jan 2003 A1
20030040239 Toas et al. Feb 2003 A1
20030044513 Shah et al. Mar 2003 A1
20030066523 Lewis et al. Apr 2003 A1
20030071879 Swenson Apr 2003 A1
20030116294 Kehrer et al. Jun 2003 A1
20030134945 Capps Jul 2003 A1
20030148084 Trocino Aug 2003 A1
20030153690 Husemoen et al. Aug 2003 A1
20030185991 Wigger et al. Oct 2003 A1
20030203117 Bartkowiak et al. Oct 2003 A1
20040002567 Chen et al. Jan 2004 A1
20040019168 Soerens et al. Jan 2004 A1
20040024170 Husemoen et al. Feb 2004 A1
20040033269 Hei et al. Feb 2004 A1
20040033747 Miller et al. Feb 2004 A1
20040034154 Tutin et al. Feb 2004 A1
20040038017 Tutin et al. Feb 2004 A1
20040048531 Belmares et al. Mar 2004 A1
20040077055 Fosdick et al. Apr 2004 A1
20040079499 Dezutter et al. Apr 2004 A1
20040087024 Bellocq et al. May 2004 A1
20040087719 Rautschek et al. May 2004 A1
20040122166 O'Brien-Bernini et al. Jun 2004 A1
20040131874 Tutin et al. Jul 2004 A1
20040144706 Beaufils et al. Jul 2004 A1
20040152824 Dobrowolski Aug 2004 A1
20040161993 Tripp et al. Aug 2004 A1
20040209851 Nelson et al. Oct 2004 A1
20040213930 Halabisky Oct 2004 A1
20040220368 Li et al. Nov 2004 A1
20040249066 Heinzman et al. Dec 2004 A1
20040254285 Rodrigues et al. Dec 2004 A1
20040260082 Van Der Wilden et al. Dec 2004 A1
20050001198 Bytnar Jan 2005 A1
20050017394 Hochsmann et al. Jan 2005 A1
20050027283 Richard et al. Feb 2005 A1
20050033037 Trusovs Feb 2005 A1
20050048212 Clamen et al. Mar 2005 A1
20050059770 Srinivasan et al. Mar 2005 A1
20050171085 Pinto et al. Aug 2005 A1
20050196421 Hunter et al. Sep 2005 A1
20050202224 Helbing Sep 2005 A1
20050208852 Weber Sep 2005 A1
20050215153 Cossement et al. Sep 2005 A1
20050245669 Clungeon et al. Nov 2005 A1
20050275133 Cabell et al. Dec 2005 A1
20050288479 Kuroda et al. Dec 2005 A1
20060005580 Espiard et al. Jan 2006 A1
20060009569 Charbonneau et al. Jan 2006 A1
20060044302 Chen Mar 2006 A1
20060099870 Garcia et al. May 2006 A1
20060111480 Hansen et al. May 2006 A1
20060124538 Morcrette et al. Jun 2006 A1
20060135433 Murray et al. Jun 2006 A1
20060141177 Ligtenberg et al. Jun 2006 A1
20060179892 Horres et al. Aug 2006 A1
20060188465 Perrier et al. Aug 2006 A1
20060198954 Frechem et al. Sep 2006 A1
20060231487 Bartley et al. Oct 2006 A1
20060252855 Pisanova et al. Nov 2006 A1
20060281622 Maricourt et al. Dec 2006 A1
20070006390 Clamen et al. Jan 2007 A1
20070009582 Madsen et al. Jan 2007 A1
20070027281 Michl et al. Feb 2007 A1
20070039520 Crews et al. Feb 2007 A1
20070082983 Crews et al. Apr 2007 A1
20070123679 Swift et al. May 2007 A1
20070123680 Swift et al. May 2007 A1
20070129522 Burckhardt et al. Jun 2007 A1
20070142596 Swift et al. Jun 2007 A1
20070158022 Heep et al. Jul 2007 A1
20070184740 Keller et al. Aug 2007 A1
20070191574 Miller et al. Aug 2007 A1
20070270070 Othman Nov 2007 A1
20070287018 Tutin et al. Dec 2007 A1
20070292618 Srinivasan et al. Dec 2007 A1
20070292619 Srinivasan et al. Dec 2007 A1
20070298274 Eriksson et al. Dec 2007 A1
20080009209 Clamen et al. Jan 2008 A1
20080009616 Frank et al. Jan 2008 A1
20080051539 Kelly Feb 2008 A1
20080060551 Crews et al. Mar 2008 A1
20080081138 Moore et al. Apr 2008 A1
20080108741 Van Herwijnen et al. May 2008 A1
20080160260 Wada et al. Jul 2008 A1
20080160302 Asrar et al. Jul 2008 A1
20080194738 Crews et al. Aug 2008 A1
20090169867 Kelly Jul 2009 A1
20090170978 Kelly Jul 2009 A1
20090227732 Glockner et al. Sep 2009 A1
20090301972 Hines et al. Dec 2009 A1
20090304919 Huenig et al. Dec 2009 A1
20090306255 Patel et al. Dec 2009 A1
20090324915 Swift et al. Dec 2009 A1
20100029160 Srinivasan et al. Feb 2010 A1
20100058661 Jackson et al. Mar 2010 A1
20100080976 Jackson et al. Apr 2010 A1
20100084598 Jackson et al. Apr 2010 A1
20100086726 Jackson et al. Apr 2010 A1
20100087571 Jackson et al. Apr 2010 A1
20100098947 Inoue et al. Apr 2010 A1
20100117023 Dopico et al. May 2010 A1
20100129640 Kelly May 2010 A1
20100130649 Swift et al. May 2010 A1
20100175826 Huenig et al. Jul 2010 A1
20100210595 Wagner et al. Aug 2010 A1
20100222459 Kelly et al. Sep 2010 A1
20100222463 Brady et al. Sep 2010 A1
20100222566 Fosdick et al. Sep 2010 A1
20100282996 Jaffrennou et al. Nov 2010 A1
20100301256 Hampson et al. Dec 2010 A1
20100320113 Swift Dec 2010 A1
20110021672 Crews et al. Jan 2011 A1
20110039111 Shooshtari Feb 2011 A1
20110040010 Shooshtari Feb 2011 A1
20110042303 Shooshtari et al. Feb 2011 A1
20110045966 Shooshtari et al. Feb 2011 A1
20110060095 Tutin Mar 2011 A1
20110089074 Jackson et al. Apr 2011 A1
20110135937 Swift et al. Jun 2011 A1
20110190425 Swift Aug 2011 A1
20110220835 Swift et al. Sep 2011 A1
20110256790 Toas et al. Oct 2011 A1
20110260094 Hampson et al. Oct 2011 A1
20110262648 Lee et al. Oct 2011 A1
20110263757 Rand et al. Oct 2011 A1
20110306726 Bailey et al. Dec 2011 A1
20120133073 Pacorel et al. May 2012 A1
20120156954 Eckert et al. Jun 2012 A1
20130029150 Appley et al. Jan 2013 A1
20130032749 Jaffrennou et al. Feb 2013 A1
20130047888 Mueller et al. Feb 2013 A1
20130059075 Appley et al. Mar 2013 A1
20130082205 Mueller et al. Apr 2013 A1
20130174758 Mueller Jul 2013 A1
20130234362 Swift et al. Sep 2013 A1
20130236650 Swift et al. Sep 2013 A1
20130237113 Swift et al. Sep 2013 A1
20130244524 Swift et al. Sep 2013 A1
20130323492 Finch et al. Dec 2013 A1
20140091247 Jackson et al. Apr 2014 A1
20140134909 Guo et al. May 2014 A1
20140357787 Jobber et al. Dec 2014 A1
Foreign Referenced Citations (120)
Number Date Country
8538765 Aug 1985 AU
9640921 Jul 1997 AU
1090026 Nov 1980 CA
2037214 Sep 1991 CA
2232334 Nov 1998 CA
2458333 Dec 1999 CA
2278946 Jan 2000 CA
2470783 Dec 2004 CA
1251738 May 2000 CN
1905054 Aug 1969 DE
4142261 Jun 1993 DE
4233622 Apr 1994 DE
4308089 Sep 1994 DE
102004033561 Sep 2005 DE
102005023431 Nov 2006 DE
0044614 Jan 1982 EP
0099801 Feb 1984 EP
354023 Feb 1990 EP
0375235 Jun 1990 EP
0461995 Dec 1991 EP
0524518 Jan 1993 EP
0547819 Jun 1993 EP
0583086 Feb 1994 EP
0714754 Jun 1996 EP
796681 Sep 1997 EP
0826710 Mar 1998 EP
856494 Aug 1998 EP
0873976 Oct 1998 EP
878135 Nov 1998 EP
0882756 Dec 1998 EP
0911361 Apr 1999 EP
915811 May 1999 EP
936060 Aug 1999 EP
976866 Feb 2000 EP
0990729 Apr 2000 EP
1038433 Sep 2000 EP
1193288 Apr 2002 EP
1084167 Sep 2002 EP
1268702 Jan 2003 EP
1382642 Jan 2004 EP
1486547 Dec 2004 EP
1522642 Apr 2005 EP
1698598 Sep 2006 EP
1767566 Apr 2007 EP
2223941 Sep 2010 EP
2253663 Nov 2010 EP
2614388 Oct 1988 FR
770561 Mar 1957 GB
809675 Mar 1959 GB
926749 May 1963 GB
1391172 Apr 1975 GB
1469331 Apr 1977 GB
1512066 May 1978 GB
1525541 Sep 1978 GB
2047258 Nov 1980 GB
2078805 Jan 1982 GB
2173523 Oct 1986 GB
2251438 Jul 1992 GB
53113784 Oct 1978 JP
57101100 Jun 1982 JP
5811193 Jan 1983 JP
61195647 Aug 1986 JP
3-173680 Jul 1991 JP
05186635 Jul 1993 JP
7-034023 Feb 1995 JP
09157627 Jun 1997 JP
10234314 Sep 1998 JP
11035491 Feb 1999 JP
11181690 Jul 1999 JP
2000327841 Nov 2000 JP
2002293576 Sep 2002 JP
2003147276 May 2003 JP
2003238921 Aug 2003 JP
2004060058 Feb 2004 JP
2005306919 Nov 2005 JP
549563 Jan 2008 NZ
1765996 Aug 1995 RU
374400 Mar 1973 SU
9007541 Jul 1990 WO
9212198 Jul 1992 WO
9534517 Dec 1995 WO
9749646 Dec 1997 WO
9936368 Jul 1999 WO
9947765 Sep 1999 WO
9960042 Nov 1999 WO
9960043 Nov 1999 WO
0058085 Oct 2000 WO
0114491 Mar 2001 WO
0159026 Aug 2001 WO
0200429 Jan 2002 WO
0206178 Jan 2002 WO
03029496 Apr 2003 WO
03071879 Sep 2003 WO
03106561 Dec 2003 WO
2004007615 Jan 2004 WO
2004076734 Sep 2004 WO
2005087837 Sep 2005 WO
2006044302 Apr 2006 WO
2006136614 Dec 2006 WO
2007014236 Feb 2007 WO
2007024020 Mar 2007 WO
2007050964 May 2007 WO
2007112335 Oct 2007 WO
2008089847 Jul 2008 WO
2008089851 Jul 2008 WO
2008141201 Nov 2008 WO
2009019235 Feb 2009 WO
2009129084 Oct 2009 WO
2010027937 Mar 2010 WO
2010139899 Dec 2010 WO
2011019590 Feb 2011 WO
2011019593 Feb 2011 WO
2011019597 Feb 2011 WO
2011019598 Feb 2011 WO
2011022224 Feb 2011 WO
2011022226 Feb 2011 WO
2011022227 Feb 2011 WO
2011138458 Nov 2011 WO
2011138459 Nov 2011 WO
2013150123 Oct 2013 WO
Non-Patent Literature Citations (246)
Entry
International Search Report and Written Opinion for PCT/EP2019/057803 (11 pages), completed Jun. 19, 2019.
International Search Report and Written Opinion for PCT/US2008/059730, completed Sep. 22, 2008.
International Search Report and Written Opinion for PCT/US2008/069046, completed Sep. 25, 2008.
International Search Report and Written Opinion for PCT/EP2011/059317, completed Jul. 15, 2011.
International Search Report for PCT/EP2008/060185, completed Oct. 23, 2008.
International Search Report for PCT/EP2011/057363, completed Sep. 5, 2011.
Ames, J.M., “The Maillard Browning Reaction—an Update,” Chemistry & Industry, No. 17, 1988, 4 pages.
“Gamma-aminopropyltrimethoxysilane,” Hawley's Condensed Chemical Dictionary, 14th Edition, John Wiley & Sons, Inc., 2002, 1 page.
Hodge, J.E., Chemistry of Browning Reactions in Model Systems, 1953, J. Agric. Food Chem., vol. 1, No. 15, pp. 928-943.
Agyei-Aye et al., “The Role of Anion in the Reaction of Reducing Sugars with Ammonium Salts,” Carbohydrate Research 2002, 337: 2273-2277.
Laroque et al., “Kinetic study on the Maillard reaction. Consideration of sugar reactivity,” Food Chemistry 2008, 111: 1032-1042.
Bjorksten et al., “Polyester Resin—Glass Fiber Laminates,” Industrial and Engineering Chemistry (1954).
Dow Corning, “A Guide to Silane Solutions,” 2005.
Knauf Data Sheet, 2006.
Molasses Corporation, United States Sugar Corporation, http://www.suga-lik.com/molasses/composition.html (Sep. 29, 2003).
Clamen, Guy, “Acrylic Thermosets: A Safe Alternative to Formaldehyde Resins,” Nonwovens World, Apr.-May 2004, pp. 96-102.
Opposition to AU 2006272595, Amended Statement of Grounds and Particulars, issued from Australian Patent Office, Jul. 6, 2012, 22 pages.
Decision re Opposition to AU 2006272595, issued from Australian Patent Office, Aug. 14, 2015, 25 pages.
Opposition to EP 1732968, Notice of Opposition: Prior Art, Scope of the Patent, Reasons for the Opposition, issued from European Patent Office, Mar. 8, 2012, 18 pages.
Decision re Opposition to EP 1732968, issued from the European Patent Office, Nov. 14, 2014, 5 pages.
Opposition to EA 019802, submitted to Eurasian Patent Office on Dec. 26, 2014, 36 pages.
Decision re Opposition to EA 019802, issued by Eurasian Patent Office on Aug. 18, 2015, 15 pages.
Owens Corning Retiree Update: What Goes Around, Comes Around: A tale of Natural Binders, revised Mar. 20, 2013 p. 4.
A.P. Bryant, “The Terminology of Sugars,” Industrial and Engineering Chemistry, vol. 26, No. 2, p. 231, Feb. 1934.
Food Flavor Chemistry, p. 162, Mar. 21, 2009 (English Abstract).
Viswanathan, T., “Chapter 28: Thermosetting Adhesive Resins from Whey and Whey Byproducts,” in Adhesives from Renewable Resources, ACS Symposium Series, Hemingway, R.W., et al. (Eds.), American Chemical Society, Washington, DC (1989).
Viswanathan, T., and Richardson, T., “Thermosetting Adhesive Resins from Whey and Whey Byproducts,” Ind. Eng. Chem. Prod. Res. Dev. 23:644-47, American Chemical Society, United States (1984).
Residential Energy Conservation: vol. 1, Congress of the U.S., Office of Technology Assessment (Ed.), 357 pages (Jan. 1, 1979).
Office action for co-pending U.S. Appl. No. 12/524,502 (9 pages)—dated Sep. 21, 2012.
Office action for co-pending U.S. Appl. No. 12/524,502 (9 pages)—dated Apr. 4, 2013.
Office action for co-pending U.S. Appl. No. 12/524,512 (7 pages)—dated Aug. 6, 2012.
Office action for co-pending U.S. Appl. No. 12/524,512 (9 pages)—dated Apr. 1, 2013.
Office action for co-pending U.S. Appl. No. 12/524,512 (14 pages)—dated Nov. 12, 2014.
Office action for co-pending U.S. Appl. No. 12/524,512 (9 pages)—dated Jul. 10, 2015.
Office action for co-pending U.S. Appl. No. 12/524,512 (10 pages)—dated Mar. 23, 2016.
Office action for co-pending U.S. Appl. No. 12/524,512 (13 pages)—dated Oct. 5, 2016.
Office action for co-pending U.S. Appl. No. 12/524,512 (13 pages)—dated Apr. 6, 2018.
Office action for co-pending U.S. Appl. No. 12/524,512 (15 pages)—dated Jan. 17, 2019.
Office action for co-pending U.S. Appl. No. 12/524,469 (7 pages)—dated Jun. 7, 2012.
Office action for co-pending U.S. Appl. No. 12/524,469 (8 pages)—dated Jan. 29, 2013.
Office action for co-pending U.S. Appl. No. 12/524,469 (7 pages)—dated Aug. 20, 2013.
Office action for co-pending U.S. Appl. No. 12/524,469 (9 pages)—dated Jun. 9, 2014.
Office action for co-pending U.S. Appl. No. 12/524,469 (9 pages)—dated Oct. 17, 2014.
Office action for co-pending U.S. Appl. No. 12/524,469 (9 pages)—dated Jul. 23, 2015.
Office action for co-pending U.S. Appl. No. 12/524,539 (13 pages)—dated Jun. 21, 2012.
Office action for co-pending U.S. Appl. No. 12/524,539 (13 pages)—dated Jun. 6, 2013.
Office action for co-pending U.S. Appl. No. 12/524,539 (12 pages)—dated Dec. 17, 2014.
Office action for co-pending U.S. Appl. No. 12/524,539 (7 pages)—dated Jul. 15, 2015.
Office action for co-pending U.S. Appl. No. 12/524,539 (7 pages)—dated Mar. 23, 2016.
Office action for co-pending U.S. Appl. No. 12/524,539 (7 pages)—dated Dec. 29, 2016.
Office action for co-pending U.S. Appl. No. 12/524,522 (4 pages)—dated Oct. 11, 2011.
Office action for co-pending U.S. Appl. No. 12/667,718 (5 pages)—dated Sep. 3, 2013.
Office action for co-pending U.S. Appl. No. 12/667,718 (6 pages)—dated Sep. 9, 2014.
Office action for co-pending U.S. Appl. No. 12/671,922 (10 pages)—dated Oct. 7, 2011.
Office action for co-pending U.S. Appl. No. 12/671,922 (10 pages)—dated May 10, 2012.
Office action for co-pending U.S. Appl. No. 12/671,922 (9 pages)—dated Sep. 23, 2014.
Office action for co-pending U.S. Appl. No. 12/671,922 (5 pages)—dated Apr. 4, 2016.
Office action for co-pending U.S. Appl. No. 13/388,408 (5 pages)—dated Aug. 15, 2013.
Office action for co-pending U.S. Appl. No. 13/371,829 (9 pages)—dated Dec. 20, 2012.
Office action for co-pending U.S. Appl. No. 13/371,829 (6 pages)—dated Jul. 12, 2013.
Office action for co-pending U.S. Appl. No. 13/371,829 (6 pages)—dated Aug. 12, 2014.
Office action for co-pending U.S. Appl. No. 13/637,794 (8 pages)—dated Aug. 12, 2013.
Office action for co-pending U.S. Appl. No. 13/637,794 (9 pages)—dated Mar. 26, 2014.
Office action for co-pending U.S. Appl. No. 13/696,439 (11 pages)—dated Jan. 8, 2014.
Office action for co-pending U.S. Appl. No. 13/696,452 (7 pages)—dated Jan. 13, 2015.
Office action for co-pending U.S. Appl. No. 13/696,452 (9 pages)—dated Oct. 27, 2015.
Office action for co-pending U.S. Appl. No. 13/702,144 (6 pages)—dated Jan. 10, 2014.
Office action for co-pending U.S. Appl. No. 13/702,144 (7 pages)—dated Jul. 29, 2014.
Office action for co-pending U.S. Appl. No. 13/823,818 (9 pages)—dated Mar. 26, 2015.
Office action for co-pending U.S. Appl. No. 13/866,368 (16 pages)—dated Aug. 29, 2013.
Office action for co-pending U.S. Appl. No. 13/866,368 (11 pages)—dated Apr. 16, 2014.
Office action for co-pending U.S. Appl. No. 13/866,368 (8 pages)—dated Aug. 21, 2014.
Office action for co-pending U.S. Appl. No. 13/866,419 (14 pages)—dated Sep. 20, 2013.
Office action for co-pending U.S. Appl. No. 13/866,419 (10 pages)—dated Apr. 25, 2014.
Office action for co-pending U.S. Appl. No. 13/866,419 (8 pages)—dated Oct. 9, 2014.
Office action for co-pending U.S. Appl. No. 13/866,419 (8 pages)—dated Sep. 25, 2015.
Office action for co-pending U.S. Appl. No. 13/868,233 (23 pages)—dated Aug. 13, 2013.
Office action for co-pending U.S. Appl. No. 13/868,233 (12 pages)—dated Apr. 15, 2014.
Office action for co-pending U.S. Appl. No. 13/868,233 (8 pages)—dated Oct. 7, 2014.
Office action for co-pending U.S. Appl. No. 13/868,233 (8 pages)—dated Jul. 16, 2015.
Office action for co-pending U.S. Appl. No. 13/868,238 (8 pages)—dated Jul. 16, 2014.
Office action for co-pending U.S. Appl. No. 12/976,379 (7 pages)—dated Jan. 10, 2012.
Office action for co-pending U.S. Appl. No. 12/976,379 (6 pages)—dated Jul. 27, 2012.
Office action for co-pending U.S. Appl. No. 12/976,379 (9 pages)—dated Mar. 7, 2013.
Office action for co-pending U.S. Appl. No. 12/976,379 (8 pages)—dated Aug. 20, 2013.
Office action for co-pending U.S. Appl. No. 12/599,858 (8 pages)—dated May 11, 2011.
Office action for co-pending U.S. Appl. No. 13/341,542 (8 pages)—dated Dec. 26, 2012.
Office action for co-pending U.S. Appl. No. 13/341,542 (7 pages)—dated Feb. 10, 2014.
Office action for co-pending U.S. Appl. No. 14/026,394 (6 pages)—dated Aug. 14, 2014.
Office action for co-pending U.S. Appl. No. 14/272,556 (14 pages)—dated Nov. 20, 2014.
Office action for co-pending U.S. Appl. No. 14/272,556 (12 pages)—dated Sep. 17, 2015.
Office action for co-pending U.S. Appl. No. 14/342,069 (17 pages)—dated Dec. 29, 2015.
Office action for co-pending U.S. Appl. No. 14/342,069 (22 pages)—dated Sep. 2, 2016.
Office action for co-pending U.S. Appl. No. 14/342,069 (21 pages)—dated Sep. 26, 2017.
Office action for co-pending U.S. Appl. No. 14/342,069 (21 pages)—dated Jun. 6, 2018.
Office action for co-pending U.S. Appl. No. 14/390,445 (14 pages)—dated Dec. 3, 2015.
Office action for co-pending U.S. Appl. No. 14/649,277 (9 pages)—dated Jul. 22, 2016.
Office action for co-pending U.S. Appl. No. 14/686,915 (8 pages)—dated Nov. 18, 2016.
Office action for co-pending U.S. Appl. No. 14/810,765 (7 pages)—dated Jan. 29, 2016.
Office action for co-pending U.S. Appl. No. 14/828,916 (8 pages)—dated Nov. 25, 2016.
Office action for co-pending U.S. Appl. No. 14/867,502 (9 pages)—dated Nov. 18, 2016.
Office action for co-pending U.S. Appl. No. 15/172,432 (16 pages)—dated Apr. 17, 2017.
Office action for co-pending U.S. Appl. No. 15/702,087 (5 pages)—dated Nov. 9, 2018.
Office action for co-pending U.S. Appl. No. 15/177,442 (17 pages)—dated May 19, 2017.
Office action for co-pending U.S. Appl. No. 15/378,159 (18 pages)—dated Mar. 2, 2017.
Office action for co-pending U.S. Appl. No. 15/222,122 (8 pages)—dated Nov. 20, 2017.
Office action for co-pending U.S. Appl. No. 15/310,837 (13 pages)—dated Jun. 21, 2018.
Office action for co-pending U.S. Appl. No. 15/411,972 (9 pages)—dated Mar. 28, 2017.
Office action for co-pending U.S. Appl. No. 15/411,972 (8 pages)—dated Nov. 29, 2017.
Office action for co-pending U.S. Appl. No. 15/411,972 (9 pages)—dated Jun. 14, 2018.
Office action for co-pending U.S. Appl. No. 15/116,254 (8 pages)—dated Apr. 26, 2018.
Office action for co-pending U.S. Appl. No. 15/116,254 (10 pages)—dated Aug. 15, 2018.
Office action for co-pending U.S. Appl. No. 15/116,254 (12 pages)—dated Nov. 3, 2021.
Office action for co-pending U.S. Appl. No. 15/333,670 (5 pages)—dated Dec. 8, 2017.
Office Action for co-pending U.S. Appl. No. 14/116,048 (10 pages)—dated Jun. 23, 2017.
Office action for co-pending U.S. Appl. No. 15/959,131 (8 pages)—dated Nov. 8, 2019.
Office action for co-pending U.S. Appl. No. 15/822,102 (6 pages)—dated Dec. 6, 2019.
Office action for co-pending U.S. Appl. No. 15/690,623 (7 pages)—dated May 24, 2019.
Office action for co-pending U.S. Appl. No. 15/690,623 (6 pages)—dated Jan. 9, 2020.
Office action for co-pending U.S. Appl. No. 16/357,320 (7 pages)—dated Jun. 10, 2021.
Office action for co-pending U.S. Appl. No. 16/357,320 (9 pages)—dated Dec. 29, 2021.
Office action for co-pending U.S. Appl. No. 16/357,320 (9 pages)—dated Apr. 14, 2022.
Other Information—Narrative of verbal disclosure of Brian Swift (1 page)—May 13, 2014.
Petition for Inter Partes Review of U.S. Pat. No. 8,114,210 (52 pages, filed Jun. 12, 2015 by Petitioners Johns Manville Corporation and Johns Manville, Inc.).
Declaration of Dr. Frederick J. Hirsekorn Regarding U.S. Pat. No. 8,114,210 (58 pages, filed Jun. 12, 2015 by Petitioners Johns Manville Corporation and Johns Manville, Inc. in connection with Petition for Inter Partes Review of U.S. Pat. No. 8,114,210).
1st Petition for Inter Partes Review of U.S. Pat. No. D. 631,670 (68 pages, filed Jun. 19, 2015 by Petitioners Johns Manville Corporation and Johns Manville, Inc.).
2nd Petition for Inter Partes Review of U.S. Pat. No. D. 631,670 (62 pages, filed Nov. 2, 2015 by Petitioners Johns Manville Corporation and Johns Manville, Inc.).
Decision of PTAB regarding Institution of Inter Partes Review for U.S. Pat. No. D. 631,670 (33 pages)—Jan. 12, 2016.
Decision2 of PTAB regarding Institution of Inter Partes Review for U.S. Pat. No. D. 631,670 (27 pages)—May 9, 2016.
Final Written Decision of PTAB regarding Inter Partes Review of U.S. Pat. No. D. 631,670 based on 1st Petition (56 pages)—dated Jan. 11, 2017.
Final Written Decision of PTAB regarding Inter Partes Review of U.S. Pat. No. D. 631,670 based on 2nd Petition (55 pages)—dated May 8, 2017.
Court of Appeals for Federal Circuit Judgment from Appeal of PTAB Decisions in Inter Partes Reviews of U.S. Pat. No. D. 631,670 (2 pages)—Jul. 13, 2018.
1st Petition for Inter Partes Review of U.S. Pat. No. 8,940,089 (61 pages, filed Jul. 1, 2015 by Petitioners Johns Manville Corporation and Johns Manville, Inc.).
Declaration of Dr. Frederick J. Hirsekorn Regarding U.S. Pat. No. 8,940,089 (70 pages, filed Jul. 1, 2015 by Petitioners Johns Manville Corporation and Johns Manville, Inc. in connection with 1st Petition for Inter Partes Review of U.S. Pat. No. 8,940,089).
2nd Petition for Inter Partes Review of U.S. Pat. No. 8,940,089 (56 pages, filed Jul. 10, 2015 by Petitioners Johns Manville Corporation and Johns Manville, Inc.).
Declaration of Dr. Frederick J. Hirsekorn Regarding U.S. Pat. No. 8,940,089 (67 pages, filed Jul. 10, 2015 by Petitioners Johns Manville Corporation and Johns Manville, Inc. in connection with 2nd Petition for Inter Partes Review of U.S. Pat. No. 8,940,089).
3rd Petition for Inter Partes Review of U.S. Pat. No. 8,940,089 (62 pages, filed Jul. 17, 2015 by Petitioners Johns Manville Corporation and Johns Manville, Inc.).
Declaration of Dr. Frederick J. Hirsekorn Regarding U.S. Pat. No. 8,940,089 (76 pages, filed Jul. 17, 2015 by Petitioners Johns Manville Corporation and Johns Manville, Inc. in connection with 3rd Petition for Inter Partes Review of U.S. Pat. No. 8,940,089).
Declaration of Dr. Elam Leed (11 pages, filed July 1, Jul. 10, and Jul. 17, 2015 by Petitioners Johns Manville Corporation and Johns Manville, Inc. in connection with 1st, 2nd and 3rd Petition for Inter Partes Review of U.S. Pat. No. 8,940,089, respectively).
Declaration of Dr. Jonathan Vickers (10 pages, filed July 1, Jul. 10, and Jul. 17, 2015 by Petitioners Johns Manville Corporation and Johns Manville, Inc. in connection with 1st, 2nd and 3rd Petition for Inter Partes Review of U.S. Pat. No. 8,940,089, respectively).
1st Petition for Inter Partes Review of U.S. Pat. No. 9,039,827 (60 pages, filed Jul. 29, 2015 by Petitioners Johns Manville Corporation and Johns Manville, Inc.).
Declaration of Dr. Frederick J. Hirsekorn Regarding U.S. Pat. No. 9,039,827 (72 pages, filed Jul. 29, 2015 by Petitioners Johns Manville Corporation and Johns Manville, Inc. in connection with 1st Petition for Inter Partes Review of U.S. Pat. No. 9,039,827).
2nd Petition for Inter Partes Review of U.S. Pat. No. 9,039,827 (51 pages, filed Aug. 5, 2015 by Petitioners Johns Manville Corporation and Johns Manville, Inc.).
Declaration of Dr. Frederick J. Hirsekorn Regarding U.S. Pat. No. 9,039,827 (65 pages, filed Aug. 5, 2015 by Petitioners Johns Manville Corporation and Johns Manville, Inc. in connection with 2nd Petition for Inter Partes Review of U.S. Pat. No. 9,039,827).
3rd Petition for Inter Partes Review of U.S. Pat. No. 9,039,827 (57 pages, filed Aug. 7, 2015 by Petitioners Johns Manville Corporation and Johns Manville, Inc.).
Declaration of Dr. Frederick J. Hirsekorn Regarding U.S. Pat. No. 9,039,827 (75 pages, filed Aug. 7, 2015 by Petitioners Johns Manville Corporation and Johns Manville, Inc. in connection with 3rd Petition for Inter Partes Review of U.S. Pat. No. 9,039,827).
Declaration of Dr. Elam Leed (11 pages, filed Jul. 29, August 5, and Aug. 7, 2015 by Petitioners Johns Manville Corporation and Johns Manville, Inc. in connection with 1st, 2nd and 3rd Petition for Inter Partes Review of U.S. Pat. No. 9,039,827, respectively).
Declaration of Dr. Jonathan Vickers (10 pages, filed Jul. 29, Aug. 5, and Aug. 7, 2015 by Petitioners Johns Manville Corporation and Johns Manville, Inc. in connection with 1st, 2nd and 3rd Petition for Inter Partes Review of U.S. Pat. No. 9,039,827, respectively).
Petition for Inter Partes Review of U.S. Pat. No. 9,469,747 (67 pages, filed Mar. 20, 2018 by Petitioners Johns Manville Corporation and Johns Manville, Inc.).
Petition for Inter Partes Review of U.S. Pat. No. 9,828,287 (86 pages, filed Mar. 23, 2018 by Petitioners Johns Manville Corporation and Johns Manville, Inc.).
Petition for Inter Partes Review of U.S. Pat. No. 9,464,207 (78 pages, filed Mar. 28, 2018 by Petitioners Johns Manville Corporation and Johns Manville, Inc.).
Petition for Inter Partes Review of U.S. Pat. No. 9,926,464 (74 pages, filed Mar. 30, 2018 by Petitioners Johns Manville Corporation and Johns Manville, Inc.).
Office Action Granting Ex Parte Reexamination of U.S. Pat. No. 7,888,445, dated Dec. 24, 2013, in Control No. 90/013,029, 11 pages.
Office Action Granting Ex Parte Reexamination of U.S. Pat. No. 7,772,347, dated Dec. 24, 2013, in Control No. 90/013,030, 14 pages.
Office Action Granting Ex Parte Reexamination of U.S. Pat. No. 7,854,980, dated Apr. 15, 2014, in Control No. 90/013,156, 20 pages.
Declaration of Jan Rud Andersen submitted in Ex parte Reexamination Control No. 90/013,030, as Document OTH-C, Oct. 10, 2013, 4 pages.
Final Rejection in Ex Parte Reexamination of U.S. Pat. No. 7,888,445 (20 pages)—dated Jul. 24, 2015.
Final Rejection in Ex Parte Reexamination of U.S. Pat. No. 7,772,347 (23 pages)—dated Jul. 24, 2015.
Final Rejection in Ex Parte Reexamination of U.S. Pat. No. 7,854,980 (31 pages)—dated Aug. 18, 2015.
Advisory Action in Ex Parte Reexamination of U.S. Pat. No. 7,888,445 (4 pages)—dated Oct. 6, 2015.
Advisory Action in Ex Parte Reexamination of U.S. Pat. No. 7,772,347 (4 pages)—dated Oct. 6, 2015.
Advisory Action in Ex Parte Reexamination of U.S. Pat. No. 7,854,980 (4 pages)—dated Nov. 18, 2015.
Examiner's Answer in Ex Parte Reexamination of U.S. Pat. No. 7,888,445 (8 pages)—dated Mar. 23, 2016.
Examiner's Answer in Ex Parte Reexamination of U.S. Pat. No. 7,772,347 (8 pages)—dated Mar. 23, 2016.
Examiner's Answer in Ex Parte Reexamination of U.S. Pat. No. 7,854,980 (8 pages)—dated Mar. 22, 2016.
Decision of PTAB in Ex Parte Reexamination of U.S. Pat. No. 7,888,445 (17 pages)—Sep. 29, 2016.
Decision of PTAB in Ex Parte Reexamination of U.S. Pat. No. 7,772,347 (18 pages)—Sep. 29, 2016.
Decision of PTAB in Ex Parte Reexamination of U.S. Pat. No. 7,854,980 (22 pages)—Sep. 30, 2016.
Court of Appeals for Federal Circuit Judgment from Consolidated Appeal of PTAB Decisions in Ex Parte Reexamination of U.S. Pat. No. 7,888,445, U.S. Pat. No. 7,772,347 and U.S. Pat. No. 7,854,980 (5 pages)—Mar. 9, 2018.
Notice of Intent to Issue Ex Parte Reexamination Certificate for U.S. Pat. No. 7,772,347 (4 pages)—Oct. 24, 2018.
Notice of Intent to Issue Ex Parte Reexamination Certificate for U.S. Pat. No. 7,888,445 (4 pages)—Dec. 7, 2018.
Notice of Intent to Issue Inter Partes Reexamination Certificate for U.S. Pat. No. 7,888,445 (14 pages)—Sep. 24, 2020.
Notice of Intent to Issue Inter Partes Reexamination Certificate for U.S. Pat. No. 7,772,347 (13 pages)—Sep. 25, 2020.
Decision of USPTO to Reopen Prosecution in Ex Parte Reexamination of U.S. Pat. No. 7,854,980 (7 pages)—Jan. 7, 2019.
Non-final Office Action from Reopened Prosecution in Ex Parte Reexamination of U.S. Pat. No. 7,854,980 (26 pages)—dated Apr. 3, 2019.
Final Office Action from Reopened Prosecution in Ex Parte Reexamination of U.S. Pat. No. 7,854,980 (11 pages)—dated Aug. 8, 2019.
Notice of Intent to Issue Ex Parte Reexamination Certificate for U.S. Pat. No. 7,854,980 (3 pages)—Oct. 29, 2019.
Notice of Intent to Issue Inter Partes Reexamination Certificate for U.S. Pat. No. 7,807,771 (4 pages)—Jan. 30, 2014.
Notice of Intent to Issue Inter Partes Reexamination Certificate for U.S. Pat. No. 7,854,980 (6 pages)—Aug. 31, 2017.
Decision of PTAB in Inter Partes Reexamination of U.S. Pat. No. 7,888,445 (34 pages)—May 1, 2015.
Decision of PTAB in Inter Partes Reexamination of U.S. Pat. No. 7,772,347 (36 pages)—May 1, 2015.
Decision of PTAB in Inter Partes Reexamination of U.S. Pat. No. 7,854,980 (25 pages)—Jul. 30, 2015.
Remand Order of PTAB in Inter Partes Reexamination of U.S. Pat. No. 7,888,445 (5 pages)—Dec. 9, 2015.
Remand Order of PTAB in Inter Partes Reexamination of U.S. Pat. No. 7,772,347 (5 pages)—Dec. 9, 2015.
Examiner's Determination on Patent Owner Response/Requester Comments after Board Decision in Inter Partes Reexamination of U.S. Pat. No. 7,888,445 (22 pages)—Oct. 17, 2016.
Examiner's Determination on Patent Owner Response/Requester Comments after Board Decision in Inter Partes Reexamination of U.S. Pat. No. 7,772,347 (17 pages)—Oct. 17, 2016.
Court of Appeals for Federal Circuit Opinion/Judgment from Appeal of PTAB Decision in Inter Partes Reexamination of U.S. Pat. No. 7,854,980 (13 pages)—Feb. 27, 2017.
Final Decision of PTAB in Inter Partes Reexamination of U.S. Pat. No. 7,888,445 (25 pages)—Sep. 8, 2017.
Final Decision of PTAB in Inter Partes Reexamination of U.S. Pat. No. 7,772,347 (24 pages)—Sep. 8, 2017.
Decision of PTAB re Request for Rehearing in Inter Partes Reexamination of U.S. Pat. No. 7,888,445 (7 pages)—Feb. 12, 2018.
Decision of PTAB re Request for Rehearing in Inter Partes Reexamination of U.S. Pat. No. 7,772,347 (7 pages)—Feb. 12, 2018.
Court of Appeals for Federal Circuit Decision re Consolidated Appeal of PTAB Decision in Inter Partes Reexamination of U.S. Pat. No. 7,772,347 and U.S. Pat. No. 7,888,445 (14 pages)—Oct. 15, 2019.
Remand Order of PTAB in Inter Partes Reexamination of U.S. Pat. No. 7,888,445 (3 pages)—Jul. 1, 2020.
Remand Order of PTAB in Inter Partes Reexamination of U.S. Pat. No. 7,772,347 (3 pages)—Jul. 1, 2020.
Decision of USPTO Granting Ex Parte Re-exam of U.S. Pat. No. 8,114,210 (11 pages)—Apr. 9, 2020.
Decision1 of PTAB declining Institution of Inter Partes Review for U.S. Pat. No. 8,940,089 (16 pages)—Dec. 17, 2015.
Decision2 of PTAB declining Institution of Inter Partes Review for U.S. Pat. No. 8,940,089 (19 pages)—Dec. 17, 2015.
Decision3 of PTAB declining Institution of Inter Partes Review for U.S. Pat. No. 8,940,089 (14 pages)—Dec. 17, 2015.
Decision1 of PTAB declining Institution of Inter Partes Review for U.S. Pat. No. 9,039,827 (16 pages)—Jan. 4, 2016.
Decision2 of PTAB declining Institution of Inter Partes Review for U.S. Pat. No. 9,039,827 (19 pages)—Jan. 4, 2016.
Decision3 of PTAB declining Institution of Inter Partes Review for U.S. Pat. No. 9,039,827 (14 pages)—Jan. 4, 2016.
Decision of PTAB denying Institution of Inter Partes Review for U.S. Pat. No. 9,926,464 (29 pages)—Oct. 2, 2018.
Decision of PTAB denying Institution of Inter Partes Review for U.S. Pat. No. 9,464,207 (28 pages)—Oct. 2, 2018.
Decision of PTAB denying Institution of Inter Partes Review for U.S. Pat. No. 9,469,747 (29 pages)—Oct. 3, 2018.
Decision of PTAB denying Institution of Inter Partes Review for U.S. Pat. No. 9,828,287 (22 pages)—Oct. 16, 2018.
Decision of USPTO Granting Ex Parte Re-exam of U.S. Pat. No. 9,828,287 (13 pages)—Jul. 17, 2020.
Decision of USPTO Granting Ex Parte Re-exam of U.S. Pat. No. 9,464,207 (14 pages)—Jul. 31, 2020.
Decision of USPTO Granting Ex Parte Re-exam of U.S. Pat. No. 9,926,464 (18 pages)—Aug. 5, 2020.
Decision of USPTO Granting Ex Parte Re-exam of U.S. Pat. No. 8,940,089 (17 pages)—Oct. 16, 2020.
Decision of USPTO Granting Ex Parte Re-exam of U.S. Pat. No. 9,039,827 (16 pages)—Oct. 16, 2020.
Decision of USPTO Granting Ex Parte Re-exam of U.S. Pat. No. 9,469,747 (16 pages)—Nov. 9, 2020.
Decision of USPTO Granting Ex Parte Re-exam of U.S. Pat. No. 9,464,207 (19 pages)—Aug. 27, 2021.
Office Action in Ex Parte Reexamination of U.S. Pat. No. 9,464,207 (14 pages)—dated Sep. 9, 2022.
Notice of Intent to Issue Ex Parte Re-examination Certificate re U.S. Pat. No. 9,464,207 (9 pages)—Jun. 8, 2023.
Decision of USPTO Granting Ex Parte Re-exam of U.S. Pat. No. 9,926,464 (16 pages)—Sep. 7, 2021.
Office Action in Ex Parte Reexamination of U.S. Pat. No. 9,926,464 (15 pages)—dated Mar. 21, 2023.
Notice of Intent to Issue Ex Parte Re-examination Certificate re U.S. Pat. No. 9,926,464 (6 pages)—Jul. 25, 2023.
Decision of USPTO Granting Ex Parte Re-exam of U.S. Pat. No. 9,469,747 (10 pages)—Sep. 16, 2021.
Office Action in Ex Parte Reexamination of U.S. Pat. No. 9,469,747 (9 pages)—dated Feb. 28, 2023.
Notice of Intent to Issue Ex Parte Re-examination Certificate re U.S. Pat. No. 9,469,747 (6 pages)—Jul. 25, 2023.
Decision of USPTO Granting Ex Parte Re-exam of U.S. Pat. No. 8,114,210 (13 pages)—Dec. 1, 2021.
Office Action in Ex Parte Reexamination of U.S. Pat. No. 8,114,210 (11 pages)—dated Mar. 27, 2023.
Notice of Intent to Issue Ex Parte Re-examination Certificate re U.S. Pat. No. 8, 114,210 (6 pages)—Aug. 8, 2023.
Decision of USPTO Granting Ex Parte Re-exam of U.S. Pat. No. 8,940,089 (13 pages)—Jan. 28, 2022.
Office Action in Ex Parte Reexamination of U.S. Pat. No. 8,940,089 (11 pages)—dated Jul. 17, 2023.
Decision of USPTO Granting Ex Parte Re-exam of U.S. Pat. No. 9,828,287 (11 pages)—Feb. 1, 2022.
Office Action in Ex Parte Reexamination of U.S. Pat. No. 9,828,287 (9 pages)—dated Feb. 28, 2023.
Notice of Intent to Issue Ex Parte Re-examination Certificate re U.S. Pat. No. 9,828,287 (6 pages)—Jul. 25, 2023.
Decision of USPTO Granting Ex Parte Re-exam of U.S. Pat. No. 9,039,827 (13 pages)—Feb. 1, 2022.
Office Action in Ex Parte Reexamination of U.S. Pat. No. 9,039,827 (11 pages)—dated Aug. 16, 2023.
Notice of Intent to Issue Ex Parte Reexamination Certificate for U.S. Pat. No. 8,114,210 (4 pages)—May 27, 2021.
Notice of Intent to Issue Ex Parte Reexamination Certificate for U.S. Pat. No. 9,464,207 (4 pages)—Apr. 19, 2021.
Notice of Intent to Issue Ex Parte Reexamination Certificate for U.S. Pat. No. 9,828,287 (5 pages)—May 5, 2021.
Notice of Intent to Issue Ex Parte Reexamination Certificate for U.S. Pat. No. 9,926,464 (5 pages)—May 5, 2021.
Notice of Intent to Issue Ex Parte Reexamination Certificate for U.S. Pat. No. 9,469,747 (8 pages)—May 21, 2021.
Notice of Intent to Issue Ex Parte Reexamination Certificate for U.S. Pat. No. 9,039,827 (3 pages)—Jul. 2, 2021.
Notice of Intent to Issue Ex Parte Reexamination Certificate for U.S. Pat. No. 8,940,089 (4 pages)—Jul. 13, 2021.
Petition for Post Grant Review of U.S. Pat. No. 10,968,629 (50 pages, filed Jan. 6, 2022 by Petitioner Rockwool International A/S).
Denial of Petition for Post Grant Review of U.S. Pat. No. 10,968,629 entered by Patent Trial and Appeal Board (19 pages)—Jul. 6, 2022.
Statement of Revocation Grounds re GB2496951—Claimant Rockwool International (May 21, 2018, 22 pages).
Statement of Revocation Grounds re GB2451719—Claimant Rockwool International (May 18, 2018, 22 pages).
Expert Report re Revocation of GB2451719 and GB2496951—Claimant Rockwool International (Nov. 12, 2018, 11 pages).
United Kingdom Intellectual Property Office, Decision in Rockwool International v. Knauf Insulation Limited, Application under Section 72 for revocation of patents GB2451719 and GB2496951 (May 28, 2019—18 pages).
Decision of EPO Board of Appeal re Added Matter vis-à-vis EP06788492.4 (Jul. 17, 2019—14 pages).
Gogek Attorney Comments re U.S. Pat. No. 2,965,504—Apr. 6, 1960 (3 pages).
Gogek Affidavit Under Rule 132 re U.S. Pat. No. 2,965,504—Feb. 26, 1960 (3 pages).
Related Publications (1)
Number Date Country
20210130560 A1 May 2021 US
Provisional Applications (1)
Number Date Country
62662494 Apr 2018 US